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Abstract 
     Microbial biofilms are communities of microorganisms that exhibit co-operative behaviour, 
producing a matrix of exopolysaccharide that enmeshes the community. The well-studied 
human pathogens Escherichia coli and Salmonella enterica produce a biofilm matrix comprised 
chiefly of the biopolymer cellulose, along with amyloid protein fibers termed curli. This biofilm 
matrix confers surface adherence and acts as a protective barrier to disinfectants, 
antimicrobials, environmental stressors, and host immune responses. Pertaining to this 
research, the bcsEFG operon, conserved in the Enterobacteriaceae, encodes an inner 
membrane-spanning complex responsible for the addition of a phosphoethanolamine (pEtN) 
modification to microbial cellulose, essential for extracellular matrix assembly and biofilm 
architecture. Furthermore, E. coli deficient in bcsG produce a biofilm matrix lacking structural 
integrity and the self-assembling architecture observed in wild-type E. coli. The presence of a 
pEtN-substituted cellulose matrix was shown to be important in bladder epithelial colonization 
by uropathogenic E. coli, further suggesting its role as a virulence factor in etiological agents of 
urinary tract infections observed in the clinic. The purpose of this research was to characterize 
the EcBcsG enzyme, a putative pEtN transferase, by resolving its structure, understanding its 
role in pEtN substitution of the cellulose matrix in E. coli, and by elucidating its catalytic 
mechanism to enable future efforts in drug discovery. All these research objectives were 
achieved, shedding light on the biochemical basis of pEtN cellulose in E. coli.  The de novo X-ray 
crystal structure of the C-terminal catalytic domain of EcBcsG was solved using the single-
wavelength anomalous diffraction (SAD) technique phased on L-selenomethionine substituted 
EcBcsG crystals and revealed EcBcsG folds as a zinc-dependent phosphotransferase belonging 
to the pEtN transferase family. The EcBcsG active site was mapped using functional 
complementation, revealing EcBcsG shares a partially conserved active site with other known 
pEtN transferase family members, including enzymes responsible for resistance to cationic 
antimicrobial peptides (CAMPs). Using mock cosubstrates para-nitrophenyl 
phosphoethanolamine (p-NPPE) and cellooligosaccharides, the specific activity of EcBcsG was 
measured to be 11.45 +/- 0.51 nmol min-1 mg-1 in the presence of the cellulo-pentasaccharide. 
The kinetic parameters were measured as Km = 1.673 ± 0.382 mM, kcat = 6.876 x 10-3 ± 4.14 x 10-
4 s-1, and kcat/Km =  4.110 ± 0.970 M s-1. The enzymatic product of this reaction was identified 
and confirmed in vitro. Finally, the covalent phospho-enzyme intermediate was isolated, 
providing evidence for an EcBcsG catalytic mechanism. The structural and functional model of 
the cellulose modifying complex, resulting from this work, provides new insight into the 
biochemical basis for the biofilm matrix of E. coli and other Enterobacteriaceae. The research 
presented here offers opportunities in structure-based drug discovery and other efforts in 
inhibiting microbial biofilms and including the possibility of limiting the resilience of biofilm-
forming pathogens. Additionally, further understanding of bcsEFG-directed 
phosphoethanolamine cellulose production may enable biosynthetic engineering of new 
cellulosic materials or confer the advantages of phosphoethanolamine cellulose in new 
organisms. 
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1. Introduction 
1.1 Microbial biofilms 
 Microbial biofilms are defined as communities of microorganisms that reside in a matrix 
of extracellular polymeric substances (EPS), produced by the communities themselves, that 
adhere to other cells and/or a substratum1. Fleming and colleagues have described biofilms as 
an emergent form of bacterial life that differ substantially from free-living cells1. The properties 
of biofilms cannot be predicted by the study of free-living bacteria alone, and are among the 
most successful and ubiquitous life strategies on Earth1. All higher organisms, including 
humans, are colonized by at least one organism observed to form biofilms1. These communities 
are often high-cell density, containing  over 108 cells per gram of wet weight1. The composition 
of these biofilms can be highly heterogeneous, both in the species composition and the gene or 
protein expression of the constituent cells1,2. This heterogeneity is driven by the interplay 
between communication, co-operation, competition, and the occurrence of ecological 
microgradients within the biofilm1–3.  As a result, the biofilm matrix serves as an interface 
between its constituents and their outside environment, serving many roles to the benefit of 
the microorganisms that may justify the large resource cost of producing copious quantities of 
extracellular matrix material1. For example, biofilms have been observed to serve in resource 
capture1,4–6, accelerated cell growth7, and the tolerance of stressors or disinfectants, such as 
shearing forces1,3,7, dessication1,8, antimicrobial compounds1,3,9,10, extreme temperature1,3,11, or 
sanitizing agents1,3,4,9. Thus, biofilms not only confer emergent properties that have enhanced 
the success of microorganisms on Earth, they provide constituent cells resilience, persistence, 
and diversity1 that has made them a subject of research interest. For example, the formation of 
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biofilms by pathogens pose significant problems to human health, as biofilm formation can 
occur within the host, on medical devices or implants, or on surfaces of healthcare facilities and 
equipment1,3. In these environments, biofilms would confer enhanced resistance of these 
pathogens to antimicrobial drugs and disinfectants commonly used to treat infection and 
contamination, enhancing the survival of biofilms as compared to free-living cells1,3,12. Fux et al. 
estimate that biofilms may be implicated in greater than 60% of resistant infections observed 
by physicians in the clinic3, making them significant in the study of infectious disease. The 
formation of biofilms has also been observed in many foodborne microbial pathogens, 
enhancing their ability to persist through food preservation, packaging, and preparation or 
cooking1. Thus, the persistence of foodborne pathogens or spoilage organisms may also result 
in devastating economic losses through product recalls and workforce illnesses. The formation 
of biofilms in water treatment facilities, water distribution pipes and on the surface of 
underwater infrastructure also pose problems to human health and economics1,3. The study of 
biofilms is not, however, limited to pathogens. Several biofilm-forming species have been 
applied to the study of new materials13, wound dressings, polymer science, or water treatment 
and biocontrol strategies1,13.  
 Microbial biofilms are considered a distinct form of life from motile and planktonic cells, 
and the mechanisms that govern their formation have been reported extensively. Biofilms are 
formed by planktonic cells through a reversible, then irreversible attachment to a substratum 
and/or other cells  via type IV pili, fimbriae or other cell-surface mediated adhesion 
mechanisms11,14,15. Various cellular signalling events further drive cell division and 
differentiation that results in the disassembly and downregulation of motility-associated 
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factors, including flagella, and culminate in the secretion of exopolysaccharides and 
proteinaceous factors that begin to enmesh the growing community16,17. Many independent 
reports conclude that heterogeneity is largely responsible for the complex architecture 
observed in mature biofilms16–18, forming highly ordered and differentiated three-dimensional 
structures that include channels for the exchange of nutrients, solvent, gases, metabolic 
wastes, and the flow of cells into or out of the biofilm. Metabolic differentiation also confers 
important emergent properties to biofilms, including altered susceptibility to antimicrobial 
drugs, the cooperative exchange of resources, and the accumulation of extracellular enzymes 
that aid in defence, cooperativity and nutrient exchange1. Transitioning from a mature biofilm 
to a planktonic cell or cells is also possible, and participation in a biofilm is a reversible process 
as entry and exit to the biofilm phenotype is a dynamic and regulated process1. 
 Beyond the heterogeneity and the overwhelming diversity observed in biofilms, the 
single unifying and defining characteristic of biofilms are the extracellular matrices that encase 
the communities within them. Biofilm matrices themselves are complex, self-assembling 
structures composed primarily of structurally diverse carbohydrates and proteins, but may also 
include secreted extracellular DNA, lipids, and other non-structural molecules1. In addition to 
these complex carbohydrate polymers, the existence of large, high molecular-weight amyloid 
protein fibers has been described in large quantities1,5,10,11,19. The identity of the 
exopolysaccharides that compose an individual biofilm is highly variable, with different 
organisms producing different exopolysaccharides in their biofilms, both between and within 
species1,20. Isolates of a single organism may produce different exopolysaccharides with vastly 
different compositions under different conditions, or may produce no EPS at all under 
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others1,14,20,21, and the presence of multiple genetic elements linked to the production of a 
variety of EPS components within a single organism is also not uncommon1,14,22. For example, 
the bacterium Pseudomonas aeruginosa is capable of producing the exopolysaccharides 
alginate, Pel, and Psl, although not concomitantly23. Despite their apparent importance and 
near-ubiquity, still little is known about the biochemical basis of EPS biosynthesis, export, and 
self-assembly into the complex biofilm matrix. However, it is generally understood that EPS 
biosynthesis is carried out by pathways described as “synthase-dependent”24. These pathways 
are differentiated from others that function in the biosynthesis and export mechanisms of 
other cell-surface carbohydrates in microorganisms, such as the cell wall, lipopolysaccharide, or 
capsular polysaccharide24. These structural differences are attributed to the nature of the 
polymer, where capsular or lipopolysaccharides are assembled on a lipid acceptor and are 
shuttled to the cell surface where they remain attached, whereas, exopolysaccharides are 
freely secreted at the cell surface and, thus, unique mechanisms for their biosynthesis are 
necessitated23,24.  
1.2 Synthase-dependent pathways 
 As described above, the composition of the biofilm matrix is variable between microbial 
species, and in some cases, may also vary within a single species, as some organisms may 
possess the means to produce multiple biofilm components under different conditions7. In 
contrast, one unifying feature of these biofilms is that all matrix compositions described at 
present contain some kind of carbohydrate component24. Many of these carbohydrate 
components can be isolated as high molecular weight, unbranched polysaccharide chains24. The 
biosynthesis of these EPS carbohydrate polymers do not share any physiological mechanisms 
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with other well-studied bacterial metabolic pathways of other cell-surface carbohydrates, such 
as lipopolysaccharide or capsular polysaccharide. For example, the Wzx-Wzy dependent-
pathway is used to assemble the cell-surface carbohydrate O antigen, found as the outer layer 
of lipopolysaccharide in Gram negative bacteria (Fig. 1)25. In this system, glycosyltransferases 
polymerize the base repeating saccharide chains of O antigen on a lipid acceptor, undecaprenyl 
pyrophosphate (UndPP) on the cytoplasmic face of the inner membrane25. The Wzx flippase 
then flips the UndPP lipid to the periplasmic face of the membrane via cation-driven antiport25. 
The lipid-linked saccharide unit is transferred to the Wzy polymerase, where it adds a repeating 
saccharide unit to the reducing end of the growing polymer, one unit at a time25. The length of 
the polymer is then regulated by the Wzz protein, followed by ligation to the lipid A core of 
lipopolysaccharide25. Alternatively, biosynthesis of other cell-surface polysaccharides, such as 
Figure 1: Pathways for the biosynthesis & assembly of cell-surface glycans in Gram-negative bacteria. 
Lipid-linked glycans, such as lipopolysaccharide or capsular polysaccharide, are assembled on lipid 
anchors and shuttled to the outer membrane via the Wzx/Wzy dependent pathway (A) or by ATP-
binding cassette (ABC) transport (B). Exopolysaccharides biosynthesis and export is instead carried out 
by synthase complexes (C). PCP: polysaccharide co-polymerase, OPX: outer membrane polysaccharide 
export, NDP/NMP: nucleotide diphosphate/monophosphate, OM: outer membrane, IM: inner 
membrane, PG: peptidoglycan. Model adapted from Whitney and Howell (2013; Ref. 24). 
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spore coat or capsular polysaccharide, is carried out in the cytoplasm by cytosolic 
glycosyltransferases on lipid cores24, and translocation to the periplasm is carried out by ATP-
binding cassette (ABC) transporters (Fig. 1)24,25. Export of these lipid-linked polysaccharides is 
then carried out by the polysaccharide co-polymerase and outer membrane export systems, a 
series of homologous systems in Gram-negative bacteria that transport a diverse set of lipid-
linked glycans to the outer membrane of the cell26,27. 
 The free secretion of the EPS components at the cell surface differentiates them from 
the above mentioned glycans and, thus, necessitates their unique biosynthetic pathways to be 
independent of lipid acceptors. The biosynthesis of EPS components is instead thought to be 
carried out by a series of pathways termed “synthase-dependent”, where the EPS is 
polymerized at the inner membrane and transiently anchored to a synthase complex, allowing 
for free secretion at the cell surface following polymerization and export24. Similar to the other 
described cell-surface glycan biosynthesis pathways, these synthase-dependent pathways all 
share common structural characteristics24,28, although the individual proteins responsible vary 
based on the EPS they serve to polymerize and export. In Gram-negative bacteria, the focus of 
this research, these synthase-dependent pathways form a trans-envelope complex24 spanning 
the inner and outer membranes and traversing the periplasmic space (Fig. 1). In Gram-positive 
organisms, these synthase complexes reside in the cytoplasmic membrane and facilitate the 
direct export of the nascent polymer to the extracellular space. 
 At present, our understanding of the major components of the Gram-negative synthase-
dependent pathway include the involvement of a synthase complex24,29, an outer membrane 
secretin complex24,28, and various periplasmic components found to be important for 
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processing of the EPS polymer5,20,30,31. The polymerization of the EPS polymer is carried out by 
the synthase complex, canonically containing a glycosyltransferase domain, responsible for 
polymerizing the EPS from its metabolic precursor29, and a regulatory PilZ domain responsible 
for binding cyclic dimeric guanosine monophosphate (c-di-GMP)9, an important second 
messenger molecule in bacteria with a demonstrated physiological role in transcription of 
community-associated genes and enzymatic activation of their gene products12,13. 
 Polymerization of the EPS glycan is linked to translocation through the synthase complex 
and into the periplasm, where often the nascent polymer may be enzymatically modified by 
transferases32, esterases33–35, epimerases36, hydrolases24,30,37, or a combination of these20. 
Finally, export is carried out through an outer-membrane secretin28, composed of a β-barrel 
porin24 in the outer membrane and a tandem-tetratricopeptide repeat (TPR), either as an 
accessory domain to the porin, or as a separate protein anchored to the outer membrane28,38. 
Together, these biosynthetic genes are operon-encoded, and are upregulated as part of the 
motile-to-sessile physiological transition in response to cellular signalling events, typically 
centered around c-di-GMP metabolism22.  
1.3 Microbial cellulose 
      Among the diverse host of biofilm EPS components, microbial cellulose is one EPS matrix 
produced by biofilm-forming bacteria of clinical and economic importance14. The cellulose 
biofilm was first described in Gluconacetobacter xylinus (formerly Acetobacter xylinus), forming 
a large pellicle composed chiefly of cellulose at the air-liquid interface39, and the later discovery 
of cellulose in the well-studied human pathogens E. coli and Salmonella enterica14,19 highlight 
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its importance. To date, the production of a biofilm composed of the exopolysaccharide 
cellulose has shown importance to Acetobacter, Sarcina, Rhizobium, Agrobacterium, 
Cronobacter and Pseudomonas species, among others, to form symbiotic and pathogenic 
interactions5,40,41. Although they share the same name, bacterial cellulose is structurally distinct 
from plant cellulose, as the former demonstrates malleability and high water-retention as 
compared to the latter. These properties make bacterial cellulose highly useful for medical 
applications and wound dressings, as a low cost natural product that can accelerate healing, 
decrease pain, and greatly lowers the probability of infection for severe burns42. Because of its 
inert and non-immunogenic nature, biocompatibility, and relative resistance to degradation, 
bacterial cellulose has quickly become a major research topic in the modern biomedical 
industry13.  
 Microbial cellulose is produced as a linear polymer of β-(1,4) linked glucose, although it 
has been shown to be chemically modified in some cases43. In the case of unmodified microbial 
cellulose, hydrogen bonding occurs between hydroxyl groups, facilitating the formation of 
dense, fibrous and microcrystalline ultrastructure of the cellulose chains43. For this reason, 
microbial cellulose has high tensile strength and low water retention, making it the subject of 
study for materials science where it has seen application in wound dressings and stitches39,43,44. 
Moreover, heterogeneity in the structure and assembly of cellulose biofilms have garnered 
research interest into what shapes these discrete extracellular matrices and the specific 
properties they confer to constituent bacteria. To date, at least three distinct subgroups of 
microbial cellulose have been described5,32,45, which are discussed in further detail below, but 
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all require the essential synthase-dependent components that assemble and export the 
cellulose exopolysaccharide. 
1.4 The bacterial cellulose synthase-dependent exopolysaccharide biosynthetic machine 
 
 All cellulose-producing bacteria possess the core bcsABCZ operon, or homologues 
thereof, containing the essential biosynthetic machinery for the production and export of 
cellulose chains, with the notable absence of outer-membrane localized components in Gram-
positive organisms43. The BcsA enzyme and its homologues have been demonstrated to be the 
synthase component in the bacterial inner membrane, possessing processive 
glycosyltransferase activity29. The identification of BcsA/BcsB as the catalytically active 
glycosyltransferase and the resolution of the bacterial cellulose synthase by X-ray 
crystallography represented  significant milestones in the contemporary understanding of 
bacterial cellulose biosynthesis29,46. The BcsA glycosyltransferase domain catalyzes the addition 
of a single glucose residue at a time to the growing chain from a uridine 3’-diphosphate (UDP) 
linked donor molecule, originating from the bacterial cytoplasm29. BcsA also possesses a PilZ c-
di-GMP binding domain29, found in other c-di-GMP-responsive proteins6,22, responsible for 
control of its glycosyltransferase activity. BcsB forms a heterodimer with BcsA and has been 
shown to be necessary for BcsA activity and cellulose production both in vivo47 and in vitro29.  
Together, the BcsA/B complex also facilitates the translocation of nascent cellulose chains to 
the periplasmic space via a hydrophilic channel in BcsA and carbohydrate-binding domain in 
BcsB29,48. 
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Secretion of the cellulose polymer across the outer membrane is necessary for Gram-
negative organisms, and is thought to be carried out by a class of homologous secretin 
complexes encoded on synthase-dependent operons24,38. The BcsC protein, and its synthase-
dependent homologues belong to this novel class of exopolysaccharide secretins28,38. A large β-
barrel domain in the outer membrane forms a pore for export that matches the chemical 
nature of the EPS polymer24. For example, BcsC is thought to form an uncharged hydrophilic 
channel of 8Å diameter, suitable for cellulose secretion38, while AlgE of the alginate EPS system 
possesses a series of positively-charged periplasmic loops to facilitate the movement of the 
anionic alginate polymer49,50. A TPR region is also present in BcsC and other EPS synthase 
homologues, and is thought to serve as a scaffold, both for assembling the synthase complex 
Figure 2: The bacterial cellulose synthase biosynthetic machine. Polymerization of cellulose chains from 
cytoplasmic UDP-glucose is carried out by the BcsA glycosyltransferase under positive regulation by the second 
messenger molecule cyclic dimeric guanosine monophosphate (c-di-GMP). Periplasmic translocation is coupled 
with synthesis and accomplished by the BcsA/BcsB heterodimer. Finally, export is achieved through the BcsC outer 
membrane secretin. The periplasmic endoglucanase BcsZ is thought to be a negative regulator of the biofilm 
phenotype and inversely expressed with the synthase components. Model based on Whitney and Howell (2013; 
Ref. 24). 
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through protein-protein interaction as observed in other TPR-containing proteins, but also by 
guiding the polymer through the periplasmic space and interacting with the peptidoglycan cell 
wall in some way28,38. Finally, the BcsZ enzyme possesses endo-β(1-4)-glucanase activity, 
colloquially referred to as a cellulase enzyme, and is responsible for degradation of cellulose 
polymers from within the chain30,48. The activity of BcsZ may be responsible for suppression of 
the biofilm phenotype and serve to initiate acute infection and virulence30, enabling rapid 
transition to motility and host pathogenicity in some organisms. Also identified is the BcsQ 
protein, thought to be a MinD homologue responsible for the polar localization of cellulose 
synthase complexes at terminal cell poles and regulating the end-to-end cellular architecture 
observed in biofilm phenotypes43.  
An understanding of the regulation and assembly of the synthase complex remains 
elusive, largely due to the complex and transient protein-protein interactions that shape it. At 
present, it is understood that the assembly of synthase-dependent complexes occurs through 
at least two distinct mechanisms: first, a molecular checkpoint ensures correct protein folding, 
membrane insertion and protein-protein interaction of the synthase complex51, and 
subsequently, c-di-GMP binding serves to both enzymatically activate the complex and promote 
its proteolytic stability52,53. Furthermore, it appears that loss of c-di-GMP binding or complex 
ultrastructure is correlated to downregulation of the synthase components and upregulation of 
the BcsZ glycosyl hydrolase expression51, although its specific role, perhaps in periplasmic or 
extracellular clearance of the cellulose exopolysaccharide remains to be demonstrated. 
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1.5 Microbial crystalline cellulose 
 The initial discovery of microbial cellulose and the bcsABCZ operon in Acetobacter 
xylinus enabled the identification of many more operons in a diverse subset of bacteria that 
produce cellulose as part of their extracellular matrix40,54. Only following the description of 
modified cellulose exopolysaccharides, and their biofilm phenotypes, did it become clear that 
unmodified cellulose exopolysaccharides were responsible for a discrete biofilm morphotype of 
their own. The identification of acsD in the proteobacterium Acetobacter hansenii and xcsB in 
the cyanobacterium Thermosynechococcus vulcanus suggested that a periplasmic adaptor 
protein may serve as a funnel for the coupling of individual cellulose fibrils into nanocrystalline 
fibers, shaping the biofilm architecture of the unmodified cellulose exopolysaccharides45,55. The 
apparent structural similarity of the XcsB periplasmic component of the cyanobacterial cellulose 
Figure 3: Crystalline cellulose biosynthesis. The proposed bacterial cellulose synthase pathways in the 
cyanobacterium Thermosynechococcus vulcanus (left) and the proteobacterium Acetobacter hansenii (left). The 
presence of a periplasmic adaptor protein in these species may be related to the bundling of cellulose into 
crystalline fibers in their biofilms. Adapted from Maeda et al (2018; Ref 45) and Hu et al. (2016; Ref 47). 
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synthase to the HlyD component of bacterial tripartite efflux pumps suggest that cellulose 
secretion in cyanobacteria may be mechanistically unique from the Proteobacteria45,56. Despite 
this heterogeneity, numerous reports in the literature demonstrate that the essential 
components for cellulose production include the synthase complex itself, and the outer 
membrane secretin22,29,39,47, and that the lack of accessory periplasmic components is generally 
correlated with the production of unmodified, crystalline cellulose nanofibrils in the biofilm. 
1.6 Microbial acetylcellulose 
 The first report of microbial acetylcellulose was reported by Spiers and colleagues5 who 
demonstrated that an unusual, “wrinkly spreader” biofilm phenotype of Pseudomonas 
fluorescens SBW25 was driven by the production of a modified cellulose exopolysaccharide. In 
addition to the operon-encoded, core synthase-dependent biosynthetic machinery needed to 
produce cellulose, this organism also possessed additional genetic components whose deletion 
resulted in the secretion of an unmodified cellulose exopolysaccharide with different physical 
characteristics5. The acetylation of other carbohydrate polymers in bacteria has been described, 
including pathways for the O-acetylation of the essential cell wall polymer peptidoglycan57,58 or 
the O-acetylation of the exopolysaccharide alginate, first described in P. aeruginosa20,23. The 
enzymes encoded on this acetylcellulose operon share sequence similarity with both the 
bcsABCZ synthase complex and the algXFIJ acetylation pathway that produces the 
exopolysaccharide alginate, a hemiacetylated polysaccharide consisting of (1-4)-linked β-D-
mannuronic acid and α-L-guluronic acid also produced via a synthase-dependent system. Insight 
into these mechanistic pathways of polymer O-acetylation have been reported extensively in 
the literature and provide a structural and biochemical basis for acetylation of these polymers. 
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Generally, an unknown acetyl donor, likely acetyl coenzyme A, provides the acetyl group to a 
membrane-bound O-acetyltransferase (MBOAT) in the inner membrane20,23,58. This acetyl group 
is then subsequently transferred to periplasmic protein components that serve to covalently 
attach this acetyl group to the polymer in the periplasmic space20,58,59. 
The essential functions for production and secretion of these acetylcellulose polymers are 
carried out by the wrinkly spreader structural, or wssBCDE and wssFGHI operons, named so 
after the multicellular morphotype their expression confers5. The wssBCDE operon encodes 
predicted homologues of the bcsABCZ operon, including a synthase complex (wssB/wssC), an 
outer membrane secretin (wssE) and a glycosyl hydrolase (wssD)5,20,23. The role of the wssFGHI 
gene products in cellulose O-acetylation is not well understood at present, although their 
Figure 4: Acetylcellulose biosynthesis. While the molecular mechanisms that govern cellulose O-acetylation have 
yet to be elucidated, it is generally believed that the wssFGHI operon encodes a series of proteins responsible for 
shuttling an acetyl group from a cytoplasmic donor, likely acetyl coenzyme A, to the exopolysaccharide in the 
periplasmic space. Adapted from Whitney and Howell (2013; Ref 24). 
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sequence similarity suggests they play an analogous role to the alginate O-acetylation proteins 
algXFIJ, and to a lesser degree, to the Gram-negative peptidoglycan O-acetyltransferase 
proteins patAB5,31. Initial acceptance of an acetyl group from a cytoplasmic donor by WssH, 
which shares sequence similarities with the membrane-bound O-acetyltransferases PatA and 
AlgI, whose function are well-characterized23,58. The shuttle of these acetyl groups from the 
membrane-bound O-acetyltransferase to the nascent exopolysaccharide in the periplasmic 
space is then carried out by WssF, WssI, and possibly WssG, evidenced by the sequence 
similarity of these proteins to AlgX, AlgJ and AlgF, respectively5. These alginate O-
acetyltransferase components have been shown to have separate and distinct roles in polymer 
acetylation, despite having similar sequences and functional roles31. 
1.7 Microbial phosphoethanolamine cellulose 
 The identification of phosphoethanolamine (pEtN) cellulose was reported by 
Thongsomboon et al.32 based on discoveries by McCrate et al. that the extracellular matrix of E. 
coli UTI89 harbors a modified form of cellulose10. Solid-state nuclear magnetic resonance 
(NMR) experiments on the isolated extracellular matrix of E. coli  demonstrated that its biofilm 
was composed of amyloid curli fibers and pEtN cellulose32. Despite the acknowledgement of 
cellulose synthase operons in the Enterobactericeae11,22,39,60, it was long thought that these 
organisms produced unmodified cellulose strands as the pEtN evaded detection by traditional 
methods, often lost by treatments with acid or base that were commonplace in the isolation of 
the matrix material from the biofilm32. Instead, the mature polymer isolated from several 
strains of pathogenic E. coli and Salmonella enterica is a cellulose chain of which every-other 
glucose unit is substituted at the C6 hydoxyl with an O-phosphorylethanolamine group32. 
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Similar to the phenomenon observed in acetylcellulose5, this modification with 
phosphoethanolamine conferred unique physical properties to the biofilm that were lost with 
its absence, and these properties appear important in the colonization of hosts of pathogenic 
Enterobactericeae32,61 
 The biochemical basis for the phosphoethanolamine substitution of microbial cellulose 
has not yet been demonstrated. However, an additional bcsEFG operon has been reported 
adjacent to the bcsABCZ operon in many cellulose-producing members of the 
Enterobacteriaceae, termed Type II operons in the literature22,60. Until recently, the role of this 
secondary bcsEFG operon remained largely unknown. Romling et al. reported that deletion of 
the operon in S. enterica demonstrated reduced, but detectable cellulose production39.  Fang et 
al.62 reported that the BcsE protein represented a new class of c-di-GMP receptors62. 
Thongsomboon et al.32 further demonstrated that deletion of bcsG, and to a lesser degree, bcsE 
and bcsF resulted in a reduction or loss of phsophoethanolamine substitution of cellulose in E. 
coli and S. enterica. The proposed model of bcsEFG involves assembly into an inner membrane-
spanning complex responsible for phosphoethanolamine substitution of microbial cellulose. 
This complex is suggested to be regulated by c-di-GMP binding, independently of the BcsAB 
synthase complex32. Sequence analysis and mutagenesis suggest that bcsG encodes the key 
phosphoethanolamine transferase enzyme responsible for the covalent phosphoethanolamine 
modification of the cellulose exopolysaccharides in the Enterobacteriaceae32. 
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1.8 Phosphoethanolamine transferases 
The substitution of polysaccharides with pEtN outside the context of this research has 
been described in the literature. Several pEtN transferases that serve to substitute 
lipopolysaccharide with pEtN have been reported63–66. Lipopolysaccharides are high-molecular 
weight glycolipids composed of a lipid A glycophospholipid, an inner and outer core branched 
glycan, and an outer unbranched glycan repeating unit. Lipopolysaccharides are also antigenic 
determinants – the outer repeating glycan units of these molecules referred to as “O antigen”, 
as the lipopolysaccharide layer of unique bacterial isolates demonstrate significant structural 
variability both between species or strains and across isolates of the same species or strain67. 
Figure 5: Phosphoethanolamine cellulose biosynthesis. The accessory bcsEFG operon in the Enterobacteriaceae is 
proposed to encode a novel c-di-GMP receptor and a phosphoethanolamine transferase responsible for 
modification of the exopolysaccharide. PtdEtN: phosphatidylethanolamine, DAG: diacyldlycerol, pEtN: 
phosphoethanolamine. Adapted from Thongsomboon et al. (2018; Ref 32). 
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The lipid A component is synthesized by a conserved pathway of nine sequential enzymes67 that 
assemble the metabolic precursor, UDP-N-acetylglucosamine into lipid A-Kdo2, which becomes 
the ultimate acceptor of core sugars67,68. Lipid A structure may vary widely both within and 
between species based on subtle structural changes in the lipid A biosynthetic enzymes and 
their regulation67. The surface O-antigen is assembled separately, and varies based on the 
activity of many diverse glycosyltransferases, and is often strain specific with over 160 
described O-antigen variants found in E. coli alone64,68. Further variability of the mature LPS 
structure is attributable to the activity of aforementioned phosphoethanolamine transferases 
that further decorate these glycans, either at the lipid A glycophospholipid, or the core 
saccharides, and enhance their variability64,68–71.  
Figure 6: Lipid A and lipopolysaccharide structure. The addition of pEtN to lipid A (left), or to core 
oligosaccharides (right) of the mature lipopolysaccharide molecule confers resistance to polymyxins, 
cathelicidins, and alpha- or beta-defensins. A representative lipopolysaccharide structure from E. coli 
K12 is shown based on work by Washazaki et al. (2016; Ref. 71), with phosphorylation or pEtN 
modification sites annotated in red.  
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The strong negative charge of the lipid A glycophospholipid at the cell surface serves as 
the binding site for cathelicidins; antimicrobial peptides of the vertebrate innate immune 
system, defensins; antimicrobial peptides found in vertebrates, invertebrates and some plants, 
and polymyxins; a class of cyclic, cationic antimicrobial peptides (CAMPs) targeting Gram-
negative bacteria66,72. Pertaining to this study, polymyxins are naturally produced by various 
members of the genus Bacillus subgenus Paenibacillius and have been used as clinical 
antimicrobial drugs due to their high potency, causing cell death in milligram per liter 
conentrations66,73. The binding of polymyxins to lipopolysaccharides induces destabilization of 
the cell membrane, leading to increased permeability, cell death, and lysis74. The efficacy of 
these polymyxins is dependent upon the electrostatic interaction between the positively 
charged polymyxin and the negative charge of the phosphate groups of lipid A on the cell 
surface65. Thus, in bacteria that share an environmental niche with Paenibacillius, the 
emergence of a mechanism to shield the strong negative charge of the lipid A phosphate 
groups confers resistance to these peptides, and subsequntly, considerable selective advantage 
in such an environment75,76. The action of characterized pEtN transferases on these lipid A serve 
such a role, where a covalent pEtN modification shields the negatively charged phosphate that 
serves as the peptide binding site, both sterically with the ethyl linkage, and electrostatically 
with a positively charged amine group77. 
Today, polymyxins have been repurposed extensively for clinical use as a natural 
product antimicrobial73,75,76. Despite being nephrotoxic, polymyxins are classified as antibiotics 
of critical importance by the World Health Organization due to their activity against the rising 
threat of multidrug resistant Gram negative bacteria73. However, many species are or have 
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become intrinsically resistant to polymyxins, such as Neisseria meningitidis, Campylobacter 
jejuni, Burkholderia cepacian, and others75,76. The increased use of polymyxins in the clinic or 
for broader industrial purpose has been causally linked to the emergence of these lipid A pEtN 
transferases encoded on transferable multidrug resistance plasmids, disseminated through 
human pathogens, such as E. coli, P. aeruginosa, or Klebsiella pneumoniae, among others76. The 
flagship example, reported on widely in the literature, are the mobile colistin resistance (MCR) 
factors72,76. Based on sequence analysis, these phosphoethanolamine transferases consist of an 
N-terminal transmembrane domain that anchors them in the inner membrane of Gram-
negative bacteria and contain a C-terminal domain belonging to the alkaline phosphatase 
superfamily, which is localized to the periplasmic face of the inner membrane. Several of these 
polymyxin resistance factors have been structurally resolved and biochemically characterized. 
These enzymes modify nascent lipopolysaccharide co-synthetically, using the membrane lipid 
phosphatidylethanolamine as a donor of the modification65, first binding to the lipid via the N-
terminal transmembrane domain and cleaving the pEtN group, liberating diacylglycerol78. These 
enzymes are then predicted to proceed through a ping-pong double-displacement mechanism, 
characterized by a covalent pEtN-enzyme intermediate thats transfers the pEtN to its ultimate 
lipid A acceptor72, although the evidence for this mechanism remains limited. Furthermore, 
these enzymes possess a conserved binding site for one or more zinc cations in their active 
sites, canonical of related phosphotransferases65. This model for activity is presumed to be 
conserved throughout all known pEtN transferases, and by extension, serves as the proposed 
model for BcsG structure, activity, and mechanism. 
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2. Research Need and Hypotheses 
 
     Antimicrobial-resistant infections are predicted to be the leading cause of death worldwide 
by 2050, surpassing annual mortality by cancer and cardiovascular disease79. The emergence 
and spread of resistance to clinical antimicrobial drugs by numerous pathogens has become a 
widespread and worsening public health problem80. Such an emergence of common infections 
resistant to first- and second-line antibiotic treatment options necessitates the use of drugs by 
clinicians that may be more costly, more toxic to the patient and less efficacious for treating the 
infection80.  Furthermore, infections are being presented in the clinic that are becoming 
increasingly multidrug resistant, further reducing the treatment options available, and cases 
have been reported of several pathogens that are completely recalcitrant to all known classes 
of antimicrobial drugs80.  
 The discovery of new molecular targets for clinical therapeutics and the development of 
novel therapeutic strategies to treat multidrug resistant infections is imperative to combat the 
rising threat of antimicrobial resistance81. Biofilms serve as the first line of defence for their 
constituents, and biofilms have a demonstrated role in the colonization of the host in several 
pathogens of clinical significance – for example, Fux et al. have estimated biofilms to be 
implicated in greater than 60% of infections observed by physicians in the clinic3. Furthermore, 
the biofilm matrix itself offers both direct and indirect mechanisms to enhance the resistance of 
its constituents to clinical antimicrobial drugs1,8,82,83. These properties make biofilms an 
attractive potential target for novel therapeutics, where disruption of the biofilm may improve 
the efficacy of antimicrobial drugs against resistant pathogens or may serve as a novel 
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treatment to attenuate recalcitrant infections. The development of biofilm dispersal strategies 
may serve to improve treatment outcomes for patients dependent solely upon contemporary 
treatments centered around bactericidal drugs that are rapidly losing efficacy. Strategies based 
upon disruption of bacterial biofilms using the glycoside hydrolases encoded by bacteria 
themselves have been demonstrated in the literature to be correlated with improved 
treatment outcomes in various infection models and proof-of-concept experiments84–86.  
 Pertaining to this research, the discovery of bcsG as the essential genetic component for 
synthesis of pEtN cellulose and, thus, the architecture and assembly of the biofilm matrix makes 
BcsG an attractive target for such structure-based drug discovery. The role of pEtN cellulose in 
host colonization by the clinically important pathogens E. coli and S. enterica further 
demonstrate the research need for an understanding of the chemical biology of pEtN cellulose 
biofilms. Small molecule inhibitors of bcsG-directed pEtN cellulose biosynthesis may serve to 
attenuate the host colonization potential of multidrug resistant pathogens, serving important 
clinical roles in the treatment of antimicrobial-resistant infections that pose a rising global 
threat to public health. 
 Furthermore, an understanding of bcsEFG-directed pEtN cellulose production may 
enable biosynthetic engineering of new cellulosic materials or confer the advantages of pEtN 
cellulose in new organisms. pEtN cellulose evaded detection through decades of microbial 
cellulose research owing largely to the harsh acid hydrolysis procedures for isolating the matrix 
material10. Only recently have pEtN cellulose and the role of the bcsEFG operon been identified, 
and our understanding of this modification remains in its infancy. The biochemical basis of BcsG 
activity and the structure of the BcsEFG complex remain unexplored.  
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 We hypothesize that BcsG is functionally homologous to the phosphatidylethanolamine 
lipooligosaccharide transferases, catalyzing the metal-dependent transfer of lipid head groups 
to a cellulose exopolysaccharide acceptor. We also hypothesize a structural and biochemical 
characterization of BcsG will lead to a greater understanding of the mechanism of cellulose 
pEtN modification and the underlying molecular mechanisms of bacterial cellulose biosynthesis. 
3. Objectives 
 
    The objective of this thesis is to investigate the chemical biology of pEtN cellulose in bacteria. 
The research will focus on the gene product of bcsG from the model organism and clinically 
important human pathogen E. coli. In order to gain a meaningful understanding of this 
phenomenon, the thesis addresses three key objectives: a structural characterization of BcsG 
through crystallization, X-ray diffraction (XRD) analysis and structural modelling; a functional 
characterization of BcsG through in vitro activity assays; and an understanding of the catalytic 
mechanism of BcsG. 
3.1 Structural characterization 
 
 At the onset of this thesis, no homologous structure of BcsG was available. During this 
work, the structure of BcsG from S. typhimurium (StBcsG) was solved independently. The work 
presented here expands on the knowledge of StBcsG in three distinct ways. First, a structural 
model of the E. coli phosphoethanolamine transferase would provide significant insight to the 
enzyme fold, the catalytic mechanism, and the architecture of the active site pocket in a second 
model organism of the Enterobacteriaceae. The resolution of the EcBcsG catalytic domain 
would inform further studies aimed at elucidating its function, interpreting its relationship to 
CHARACTERIZING BcsG                                                        31 
other phosphotransferase enzymes, and designing small molecule inhibitors of BcsG activity. 
Because of the significant contributions to the current knowledge mentioned above that such a 
model would provide, a structural characterization of the BcsG catalytic domain from the model 
organism E. coli is a primary aim of this thesis.  
3.2 Functional characterization of BcsG 
 
 The bcsG gene has been established as the essential genetic component required for 
phosphoethanolamine production in the extracellular matrix of E. coli and S. enterica. However, 
at the time of writing, the enzymatic activity of BcsG had never before been demonstrated. To 
test the hypothesis that BcsG is a phosphoethanolamine transferase, a key objective of this 
thesis was to establish that the C-terminal catalytic domain of BcsG is capable of this enzymatic 
activity. 
3.2 Catalytic investigation 
 
      An understanding of the catalytic mechanism and the active site architecture is essential to 
unlocking the secrets of bcsG-directed phosphoethanolamine cellulose. At present, the active 
site and catalytic mechanism of other phosphoethanolamine transferases have been proposed 
and are supported by experimental evidence. Using this data as a model for the catalytic 
function and architecture of BcsG, this thesis will address the molecular mechanism of pEtN 
cellulose. 
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4. Experimental Methods 
4.1 Recombinant protein production 
 
The full-length open reading frame of bcsG from E. coli K12 (EcBcsG) and a truncated bcsG 
comprised of the nucleotides encoding amino acids Ala164 to Gln559 (EcBcsGΔN) were 
generated via subcloning into the pET28a overexpression vector according to the protocol by 
Cohen et al. (1973)87 to generate pBcsG and pBcsGΔN, respectively. Site-directed mutagenesis of 
these recombinant plasmids at predicted active-site residues were generated using the 
polymerase chain reaction (PCR) primer method described by Hutchison et al. (1978)88 with the 
QuikChange II SDM kit supplied by Agilent Technologies and according to the manufacturer’s 
protocol using synthetic oligonucleotide primers supplied by the University of Guelph 
Laboratory Services facility, Guelph, ON to produce the plasmids listed in Table 1 below. All 
plasmids were sequence verified at the Centre for Applied Genomics, University of Toronto, 
Toronto, ON. Summary information for the EcBcsG and EcBcsGΔN recombinant constructs are 
available in Table 2 below. A list of experimental and laboratory strains of E. coli used in this 
study are listed below in Table 3.  
Figure 7: Predicted EcBcsG topology, containing a putative N-terminal transmembrane domain and a C-
terminal catalytic domain.  
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F: forward primer, R: reverse primer, restriction sites and mutations denoted by underline 
Table 1: Recombinant plasmids and oligonucleotide primers used in this study  
Plasmid Relevant description Oligonucleotide primer sequence(s) (5’-3’) Source 
pBcsG Recombinant enzyme F:GGCGCATATGACTCAATTTACGCAAAATACC 
R:GCGCCTCGAGTTACTGCGGGTAAG 
This study 
pBcsG C243A Metal-binding mutant F:CTACTGGTGATTAACATCGCGTCGCTTTCCT
GGTCGGATATAG 
R:CTATATCCGACCAGGAAAGCGACGCGATGT
TAATCACCAGTAG 
This study 
pBcsG Y277A Substrate-binding mutant F:CCACCTCCGCGAGTGGCCCGGCGGCGATC 
R:GATCGCCGCCGGGCCACTCGCGGAGGTGG 
This study 
pBcsG Y277F Substrate-binding mutant F:GCCACCTCCTTCAGTGGCCCGGCGGCGATCC 
R:GGATCGCCGCCGGGCCACTGAAGGAGGTG
GC 
This study 
pBcsG S278A Catalytic mutant F:CCACCTCCTACGCGGGCCCGGCGGC 
R:GCCGCCGGGCCCGCGTAGGAGGTGG 
This study 
pBcsG C290A C306A Disulfide bond mutant  BioBasic 
pBcsG F329A Substrate-binding mutant F:GATGGGACATAACGGCCAGGCGGGCGGTTT
TTTGAAAG 
R:CTTTCAAAAAACCGCCCGCCTGGCCGTTATG
TCCCATC 
This study 
pBcsG H396A Substrate-binding mutant  BioBasic 
pBcsG E442A Metal-binding mutant F:GGTCGTGGTGCCGGCACACGGCGGCGCG 
R:CGCGCCGCCGTGTGCCGGCACCACGACC 
This study 
pBcsG H443A Metal-binding mutant F:GTCGTGGTGCCGGAAGCGGGCGGCGCGC 
R:GCGCGCCGCCCGCTTCCGGCACCACGAC               
This study 
pBcsGΔN Recombinant catalytic 
domain 
F:GGCGCATATGACTCAATTTACGCAAAATACC 
R:CTCCTTGCATATGGCGGGACAACC 
This study 
pBcsGΔN  C243A Metal-binding mutant F:CTACTGGTGATTAACATCGCGTCGCTTTCCT
GGTCGGATATAG 
R:CTATATCCGACCAGGAAAGCGACGCGATGT
TAATCACCAGTAG 
This study 
pBcsGΔN  Y277A Substrate-binding mutant F:CCACCTCCGCGAGTGGCCCGGCGGCGATC 
R:GATCGCCGCCGGGCCACTCGCGGAGGTGG 
This study 
pBcsGΔN S278A Catalytic mutant F:CCACCTCCTACGCGGGCCCGGCGGC 
R:GCCGCCGGGCCCGCGTAGGAGGTGG 
This study 
pBcsGΔN H396A Substrate-binding mutant F:CTACAACACGCTTCCACTGGCGGACGGCAA
CCATTATCC 
R:GGATAATGGTTGCCGTCCGCCAGTGGAAGC
GTGTTGTAG 
This study 
pBcsGΔN E442A Metal-binding mutant F:GGTCGTGGTGCCGGCACACGGCGGCGCG 
R:CGCGCCGCCGTGTGCCGGCACCACGACC 
This study 
pBcsGΔN H443A Metal-binding mutant F:GTCGTGGTGCCGGAAGCGGGCGGCGCGC 
R:GCGCGCCGCCCGCTTCCGGCACCACGAC               
This study 
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 Recombinant plasmids were introduced into chemically competent E. coli BL21 (DE3) 
supplied by Novagen as an expression host (Table 3) by incubating a mixture of cells and 
plasmid at 42°C for 1 min. These cells were allowed to recover at 4°C for 5 min, followed by 
incubation at 37°C in 500 µL of Lauria Broth (LB) media (10 g tryptone, 5 g yeast extract, 10 g 
NaCl per liter of culture). The resulting culture was spread on LB agar plates (LB plus 15g of agar 
per liter of media) containing 50 µg/mL kanamycin and incubated at 37°C for 12-18 h to select 
for successful transformants. Pure colonies were picked from this plate and used to inoculate 
20 mL of LB containing 50 µg/mL kanamycin per liter of culture. This media was incubated 12-
18 h (or until turbid) at 37°C with shaking at 220 rotations per minute (rpm). These cultures 
were used to inoculate each liter of Super Broth (SB) media (32 g tryptone, 20 g yeast extract, 
10 g NaCl per liter of culture) containing kanamycin at a final concentration of 50 µg/mL. These 
cultures were incubated at 37°C and 220rpm until an optical density at 600nm (OD600) of > 0.6 
was reached. Expression was induced by the addition of isopropyl-β-D-1-thiogalactopyranoside 
(IPTG) of 1mM, as expression of the recombinant gene is under the control of the inducible T7 
overexpression system encoded on the pET28a plasmid. Cells were harvested by subjecting the 
culture to centrifugation at 5000 x g for 15 min, decanting the supernatant, and storing the 
resulting pellet at -20°C until needed. 
†Values estimated by ProtParam tool89 
 
Table 2: Recombinant proteins used in this study   
Construct EcBcsGΔN EcBcsG 
Molecular mass (Da)† 45345 62086 
Length (residues) 417 581 
Predicted pI† 6.11 6.04 
Extinction coefficient (M-1 cm-1) λ=280 nm† 122965 49390 
His-tag N-terminal N-terminal 
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4.2 Cell lysis and recombinant protein purification 
 
Cell pellets were resuspended to homogeneity in a minimal volume of buffer A (50 mM 
Tris, 300 mM NaCl, 5 mM MgCl2 pH 8.0), typically 20 mL / L culture. Cell lysis was performed on 
this suspension using a Constant Systems cell disrupter operating at 17kpsi. The soluble cellular 
fraction was isolated from the crude lysate by subjecting it to centrifugation at 28000 x g for 45 
min to remove insoluble debris. Initial His6-tagged protein purification from the soluble cellular 
fraction was performed by immobilized metal ion affinity chromatography (IMAC). The soluble 
cellular fraction containing the recombinant EcBcsGΔN-His6 tagged fusion proteins was 
incubated in 1-3 mL nickel-nitrilotriacetic acid agarose (Ni-NTA) resin for 1 h at 4°C. The mixture 
was passed over an open column to separate the Ni-NTA from the unbound cellular fraction. 
The Ni-NTA was washed with 50 mL of buffer A, followed by washing in 50 mL of wash 1 buffer 
(buffer A with the addition of 20 mM imidazole) to remove unwanted contaminants. His6-
tagged protein was eluted from the column by the addition of 20 mL of elution buffer (buffer A 
with the addition of 250 mM imidazole) to the resin.  
Table 3: Strains used in this study. 
Strain Genotype Source or reference 
E. coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 nupG recA1 araD139 Δ(ara-leu)7697 
galE15 galK16 rpsL(StrR) endA1 λ- 
 
Invitrogen 
E. coli BL21 B F– ompT gal dcm lon hsdSB(rB–mB–) λ(DE3 
[lacI lacUV5-T7p07 ind1 sam7 nin5]) [malB+]K-
12(λS) 
 
Novagen 
E. coli AR3110 K-12 W3110 ΔbcsQ::bcsQ 32 
E. coli AR3110 ΔbcsG AR3110 bcsG::scar 32 
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Purification to homogenity was performed using size exclusion chromatography (SEC) or 
ion-exchange chromatography (IEC) where deemed necessary. Ion exchange chromatography 
was performed on a GE Akta Pure instrument using a GE Q FF HiTrap anion exchanger. Eluted 
protein from IMAC purification was buffer exchanged with dialysis 12 h against 50 mM Tris-HCl 
pH 8.0 and the sample was passed over the column twice to facilitate binding. Protein was 
eluted with a gradient of 50 mM Tris-Hcl pH 8.0 with increasing concentrations of sodium 
chloride, up to 1 M.  Fractions containing protein, typically eluting in the range of 75-150 mM 
NaCl, were pooled. Size exclusion chromatography was performed on a GE Akta Pure 
instrument using a BioRad Enrich SEC 650 column. His6-EcBcsG from IMAC purification was 
dialyzed against SEC buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 5 mM MgCl2) for 12 h. The 
resulting protein solution was concentrated to a volume of 1 mL using a GE Healthcare 
centrifugal concentrator (30,000 Da molecular weight cut-off) and loaded onto the SEC column. 
The protein was eluted with SEC buffer at a rate of 1 mL min-1 and fractions containing protein 
were pooled. The purity of protein after each purification step was assessed using SDS-PAGE 
according to the protocol by Laemmli (1970)90. Protein quantification was performed with UV 
spectrophotometry (λ = 280 nm) using a BioTek Cytation 5 imaging microplate reader and the 
molar extinction coefficients listed in Table 2. 
4.3 Functional bioassay 
4.3.1 Synthesis of paranitrophenyl phosphoethanolamine. A solution of 1.1 mL (7.11 mmol) N-
(tert-butoxycarbonyl) ethanolamine (N-Boc ethanolamine) was prepared in 20 mL of anhydrous 
tetrahydrofuran (THF). This mixture was slowly added to a vaccuum-purged and stoppered 50 
mL round bottom flask containing a solution of 3.65 g paranitrophenyl phosphodichloridate and 
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2.30 mL anhydrous pyridine in 35 mL anhydrous THF as solvent. The mixture was placed at 4°C 
for 1 h, and then placed at 20°C for a minimum of 7 h with agitation. A solution of 2.3 mL 
pyridine in 10.2 mL of water was added to this reaction mixture for 10 min with agitation. 
Following this incubation, the solvent was removed by rotary evaporation under vacuum, 
producing a faintly yellow liquid organic phase with an approximate volume of 10 mL. This 
organic intermediate was diluted in approximately 50 mL of water and washed in at least three 
50 mL volumes of ethyl acetate. The aqueous phase was acidified with two 50 mL volumes of 
5% w/v potassium bisulfate until a pH of between 3 and 4 was achieved. The desired organic 
product was extracted with three 50 mL volumes of methylene chloride. The extracted organic 
phase was washed with one 50 mL volume of saline water, dried over sodium sulfate, and 
concentrated by rotary evaporation under vacuum. This reaction intermediate was sampled 
and dissolved in deuterated chloroform for analysis by H1, C13 and F19 nuclear magnetic 
resonance (NMR) spectroscopy on an Agilent 400 MHz spectrometer. To cleave the N-Boc 
protecting group, a 72 mg quantity of the dried intermediate was dissolved in a mixture of 1 mL 
methylene chloride containing 0.1 mL trifluoroacetic acid and stirred at 20°C for at least 1 h. 
The reaction mixture was concentrated by rotary evaporation under vacuum and the residue 
was triturated with two volumes of 1 mL of ethyl acetate. The resulting product crystallized as a 
fine white crystalline solid of paranitrophenyl phosphoethanoamine (p-NPPE) trifluoroacetate. 
The crystals were washed and recrystallized in ethyl acetate. The identity of the organic product 
was verified by dissolving a small quantity in deuterated DMSO and analyzing by NMR 
spectroscopy as described above. 
4.3.2 Cellulose transferase assay. Purified EcBcsGΔN was incubated with p-NPPE as the donor of 
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the phosphoethanolamine group and cello-oligosaccharides as the ultimate acceptor for the 
transferase reaction. Unless otherwise specified, the reaction conditions were assayed with 50 
µM EcBcsGΔN in a 96-well microtiter plate (Sarstedt) using a total well volume of 100 µL with a 
buffer solution containing 50 mM HEPES pH 7.5 and 50 mM sodium chloride. The reaction 
mixtures were incubated at 37°C for 30 min and monitored every 1 min for their absorbance at 
414 nm. A standard curve (0 -100 µM) was prepared by dilution of a para-nitrophenolate 
standard solution (10 mM, Sigma) and used to calculate molar equivalents of para-
nitrophenolate released by enzymatic activity.  Negative controls were prepared with the 
absence of EcBcsGΔN from reaction mixtures. Kinetics were performed with variable 
concentrations of p-NPPE (0-10 mM) and cellopentaose (0-2.5 mM) as specified. Kinetic 
parameters were calculated using GraphPad Prism. The esterase activity of EcBcsGΔN was 
measured in the absence of cello-oligosaccharides in the reaction mixture, whereas transferase 
activity was measured indirectly in the presence of both donor and cello-acceptor substrates. 
Dithiothreitol (DTT; 1 mM) and ethylenediaminetetraacetic acid (EDTA; 1 mM) were introduced 
to EcBcsGΔN by buffer exchange for at least 12 h prior to measurement of the enzymatic rate. 
All measurements were repeated in at least triplicate. 
4.3.3 Thin-layer chromatography. Samples from the cellulose transferase assay were prepared 
for thin-layer chromatography (TLC) by centrifugation at 10,000 x g for 5 minutes to remove 
precipitate. The pellet was discarded, and the supernatant was retained as the analytical 
sample. Samples were spotted onto silica plates (Sigma) with samples at 1 cm intervals, a 
minimum distance from the solvent line of 1 cm using glass capillary tubes approximately 4-8 
times and allowed to dry 10 min between spots. The mobile phase used to separate the 
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enzymatic products was a solution of ethyl acetate, water, and methanol in an 8:3:4 ratio, 
respectively. The plate was placed in a 10 L tank, vapor-equilibrated with 50 mL of mobile phase 
and allowed to run until the solvent front reached 1 cm from the top of the plate, 
approximately 45 min – 1 h. The plate was dried by heating at 90°C on a hot plate and stained 
in a solution of 1 g/L α-napthol dissolved in methanol, sulfuric acid and water in a 25:3:2 ratio, 
respectively. The stain was developed by heating at 90°C for 5 minutes or until spots were 
visible.  
4.3.4 Liquid chromatography-mass spectrometry (LC-MS).  
Liquid chromatography–mass spectrometry analyses were performed on an Agilent 1200 HPLC 
interfaced with an Agilent UHD 6530 Q-ToF (quadrupole time-of-flight) mass spectrometer at 
the Mass Spectrometry Facility of the Advanced Analysis Centre, University of Guelph. A C18 
column (Agilent Extend-C18 50 mm x 2.1 mm 1.8 µm) was used for chromatographic separation 
with the following solvents: water with 0.1% (v/v) formic acid (A) and acetonitrile with 0.1% 
(v/v) formic acid (B). The mobile phase gradient was as follows: initial conditions were 10% B 
hold for 1 min then increasing to 100% B in 29 min followed by column wash at 100% B for 5 
min and 20 min re-equilibration. The flow rate was maintained at 0.4 mL/min. The mass 
spectrometer electrospray capillary voltage was maintained at 4.0 kV and the drying gas 
temperature at 250° C with a flow rate of 8 L/min. Nebulizer pressure was 30 psi and the 
fragmentor was set to 160. Nozzle, skimmer and octapole RF voltages were set at 1000 V, 65 V 
and 750 V, respectively. Nitrogen (purity >99%) was used as both nebulizing, drying and 
collision gas. The mass-to-charge ratio was scanned across the m/z range of 50-1500 m/z in 4 
GHz (extended dynamic range) positive and negative ion modes. Data were collected by data 
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independent MS/MS acquisition with an MS and MS/MS scan rate of 1.41 spectra/sec. The 
acquisition rate was set at 2 spectra/s. The mass axis was calibrated using the Agilent tuning 
mix HP0321 (Agilent Technologies) prepared in acetonitrile. Mass spectrometer control, data 
acquisition and data analysis were performed with MassHunter® Workstation software 
(B.04.00). 
LC-MS/MS analysis of tryptic peptides. LC-MS/MS (liquid chromatography tandem mass 
spectrometry) analyses were performed on an Agilent 1200 HPLC interfaced with an Agilent 
UHD 6530 Q-TOF mass spectrometer. Separation of the peptides was achieved by reverse-
phase HPLC using a C18 column (Agilent AdvanceBio Peptide Map, 100 mm × 2.1 mm 2.7 μm) 
previously equilibrated with 2% (v/v) acetonitrile in 0.1% (v/v) formic acid at a flow rate of 0.2 
mL min−1. Following injection of samples, a linear gradient to 45% (v/v) acetonitrile in 0.1% (v/v) 
formic acid was applied over 40 min and then to 55% (v/v) acetonitrile over 10 min. The column 
was washed with 95% (v/v) acetonitrile in 0.1% (v/v) formic acid for 5 min before re-
equilibration in starting solvent. The mass-to-charge ratio was scanned across the m/z range of 
300−2000 m/z in 4 GHz (extended dynamic range positive-ion auto MS/MS mode). Three 
precursor ions per cycle were selected for fragmentation. The instrument was calibrated with 
the ESI TuneMix (Agilent). Raw data files were loaded directly into PEAKS 7 software 
(Bioinformatics Solutions Inc.) where the data were refined and subjected to deNovo 
sequencing and database searching. The following modifications were considered within the 
search parameters: Met oxidation, and phosphorylation or pEtN-ylation of Thr, Ser, Cys, Tyr, 
and His residues. The data were searched against the EcBcsG sequence. The tolerance values 
used were 10 ppm for parent ions. 
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4.4 Functional complementation 
Cell lines. E. coli AR3110, W3110 (AR3110 bcsQ::Stop), AR3110 ΔbcsG ΔcsgBA (AR3110 
bcsG::scar, csgBA::kanR), AR3110 ΔbcsG (AR3110 bcsG::scar) and AR3110 ΔcsgBA (AR3110 
csgBA::kanR) were received from Thongsomboon and Cegelski (Standford U) as a gift. E. coli 
AR3110 ΔbcsG was made chemically competent by first culturing in TYM broth (2% [w/v] 
tryptone, 0.5% [w/v] Yeast extract, 0.1 M NaCl, 10 mM MgSO4) until an OD600 > 0.6 was 
reached. The cells were harvested by centrifugation and washed in TfB I media (10 mM MOPS, 
75 mM CaCl2, 10 mM KCl, 15% [v/v] glycerol, pH 7.0). The harvested cells were resuspended in 
TfB I media and stored at -80°C in 50 µL aliquots. These aliquots were transformed with plasmid 
according to the protocol outlined above in Section 4.1. Cell lines expressing protein variants of 
EcBcsG were generated by transforming the pBcsG derivates, whose construction is described 
in Section 4.1 above, into chemically competent E. coli AR3110 ΔbcsG. 
Pellicle macrocolony phenotype. Biofilm phenotype was assessed in triplicate by inoculating 5 
mL of salt-free LB broth containing 50 µg/mL kanamycin and incubating for 5 d at 28°C. The 
resulting biofilms were removed from the tubes by pouring in glass beakers, discarding the 
culture media, and staining the biofilms in a solution of 40 µg/mL Congo Red for at least 10 min. 
The biofilms were then washed in water and imaged on a Bio-Rad VersaDoc 4000 instrument 
using both a visible white-light filter. 
Adherence assay. The adherence potential of biofilms were assessed semi-quantitatively using 
a crystal violet assay. Eight replicates of each cell line were inoculated into 96-well microtiter 
plates with each well containing 250 µL of salt-free LB broth containing 50 µg/mL kanamycin 
and the plates incubated for 5 d at 28°C. The media was removed and the biofilms were 
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washed in three 200µL volumes of sterile phosphate buffered saline (12 mM sodium 
phosphate, 137 mM sodium chloride, pH 7.4), then stained in 200 µL of 0.1% (v/v) crystal violet 
solution. The residual crystal violet was washed away with 3 x 200 µL volumes of sterile 
phosphate buffered saline and allowed to dry for 1 h. The stained biofilm was resolubilized in 
200 µL of 30% (v/v) acetic acid and the absorbance was measured at 550 nm in a BioTek 
Cytation5 imaging plate reader. 
Expression of recombinant EcBcsG. Biofilms were grown in 96-well microtiter plates containing 
200 μL of salt-free LB with 50 μg/mL kanamycin and 250 μM IPTG at 28°C for 96 h. The biofilms 
were harvested by mechanical disruption (i.e. aspiration by micropipette) and subsequent 
ultracentrifugation at 21,100 x g for 5 min. To prepare the samples for Western blotting 
analysis, the culture media was removed, and the pellets were resuspended in SDS sample 
buffer (50 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 1 mM DTT, 0.02% w/v 
bromophenol blue) and lysed by heating at 100°C for 1 h. To assess the cellular quantity of 
EcBcsG supplied in trans, these samples were immunoblotted according to the protocol by 
Burnette (1981)91 with an antibody against the His-tag conferred by expression from the 
pET28a vector. Briefly, SDS-PAGE gels were soaked in transfer buffer (12 mM Tris-HCl, 96 mM 
glycine, 20% (v/v) methanol) and stacked on a nitrocellulose membrane pre-soaked in transfer 
buffer, loaded into a transfer apparatus (BioRad), and submerged in transfer buffer. Transfer 
was performed electrophoretically at 100 volts for 1 h 20 min with gentle stirring at 4°C. 
Transferred membranes were washed in Tris-buffered saline (TBS; 10mM Tris-HCl, 150 mM 
sodium chloride, pH 7.5) and incubated 1 h in blocking buffer (TBS with 5% (w/v) non-fat milk 
powder). Buffer was poured off and the blocked membrane was washed in Tween-Tris buffered 
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saline (TTBS; 20 mM Tris-HCl, 2 mM sodium chloride, 0.05% (v/v) Tween-20, pH 7.5), before 
incubation in primary antibody solution (Mouse anti-His IgG stock, diluted 1000-fold in blocking 
buffer) for 1 h. Antibody solution was removed, and the blotting membrane was washed twice 
with 10 mL of TTBS, then incubated in secondary antibody solution (Rabbit-anti mouse IgG-
alkaline phosphatase conjugate stock diluted 2000-fold in blocking buffer). Antibody solution 
was removed, and the blotting membrane was washed once with 15 mL of TTBS and once with 
15 mL TBS. To visualize protein bands on the membrane, the blot was washed in BCIP (5-
bromo-4-chloro-3-indolyl phosphate) and NBT (nitro- blue tetrazolium chloride) solution for 10 
min or until visible indole precipitate formed on the membrane. Blots were imaged on a BioRad 
VersaDoc 4000 system with an f-stop of 11 and an exposure time of 3 sec. 
Minimum inhibitory concentration (MIC) assay. E. coli AR3110 and E. coli AR3110 ΔbcsG were 
grown for 16 h at 37°C in sterile, cation-adjusted Muller-Hinton media (0.3% (w/v) beef extract, 
1.75% (w/v) casein acid hydrolysate, 0.15% (w/v) starch with the addition of 20 mg/L CaCl2 and 
10 mg/L MgSO4) and the final OD600nm was adjusted to 0.500 +/- 0.01 with the addition or 
removal of media. Polymyxin stocks were prepared by dissolving lyophilized peptides (Sigma) in 
Muller-Hinton media at 64 µg/mL and serially diluting in fresh Muller-Hinton media to achieve 
the concentrations tested (0-32 µg/mL). Eight replicates were tested per cell line, per peptide in 
a 96-well microtiter plate (Sarstedt). Microtiter plates containing Muller-Hinton media were 
inoculated with bacteria at a final OD600nm of 0.050 +/- 0.005 containing 200 µL of liquid media 
and incubated at 30°C for 24 h. The OD600nm was read on a Cytation5 imaging microplate reader 
(BioTek).  
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4.5 X-ray crystallography and structural modelling 
 
Seleno-L-methionine labelling. A minimal media kit for seleno-L-methionine labelling was 
purchased from Molecular Dimensions. Minimal media was prepared by dissolving 21.6 g of the 
medium base, containing sodium and potassium phosphate at pH 7.5 in 1 L of ddH2O and 
sterilized in an autoclave at 121 °C for 30 min. The media was then supplemented immediately 
prior to culture by dissolving 5.1 g of nutrient supplement (containing 4g D-glucose, trace 
vitamins, and all L-amino acids, excluding L-methionine, at a final concentration of 40 µg/mL) 
into 50mL of ddH2O and passing through a 0.45 µm syringe filter into sterile medium base. 
Kanamycin and seleno-L-methionine, at concentrations of 50 µg/mL and 40 µg/mL, respectively, 
were also supplemented aseptically prior to culture. The medium was inoculated with 50 mL of 
starter culture from LB media grown 18 h at 37°C with 220 rpm shaking. Prior to inoculation, 
the cells were separated from the media (i.e. containing unlabelled methionine) by 
centrifugation at 4000 x g for 15 min and the media discarded. The cell pellet was washed in 40 
mL of sterile ddH2O and was again separated from the water by centrifugation at 4000 x g for 
15min. The ddH2O was discarded and the cell pellet was resuspended in minimal culture media.  
Growth of protein crystals. Recombinant EcBcsGΔN was expressed and purified to homogeneity 
as outlined above in sections 4.1 and 4.2 as above for selenomethionine labelled protein. 
Prepared protein was concentrated in centrifugal filter units (30,000 Da MWCO; Pall 
Corporation) to a concentration of 1 mM. Screening of crystallization conditions was performed 
using a Crystal Gryphon instrument (Art Robins Technologies) using 1 µL volumes of protein in a 
1:1 and 2:1 ratio with the mother liquor using the sitting drop method. The commercially 
available MCSG suite (Crystalgen) was screened in its entirety for conditions permissible to 
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crystal growth. After suitable condtions were identified, protein crystals were grown using the 
hanging drop method in 24-well pregreased crystal plates (Crystalgen). Crystals were grown 
against 0.1 M HEPES:NaOH, 20% (w/v) polyethylene glycol 4000, 10% (v/v) 2-propanol, pH 7.5 
in 1:1, 2:1 and 1:2 ratios of protein solution (1 mM) over 500 µL reservoir volumes, and 
incubated at 18°C in a Molecular Dimensions crystal growth incubator. Stored plates were 
periodically observed by microscopy (Olympus SZX16 Stereomicroscope) for precipitation and 
crystal formation. The EcBcsGΔN cosusbtrates p-NPPE, cellobiose, cellopentaose, and LysoPE 
were dissolved in the crystallization condition at a concentration of 5 mM and was used to set 
up as drops with EcBcsGΔN to attempt to crystallize the enzyme-cosubstrate complex.  
X-ray diffraction analysis. Crystals were harvested from the crystal drop and subjected to 
immersion for 5-20s in a cryoprotectant solution of 55% (v/v) 2-propanol, 10% (v/v) 
poly(ethylene glycol) 4000, and 50 mM HEPES pH 7.5. The cryoprotected crystals were 
submerged in liquid nitrogen until needed. Crystals were diffracted using synchrotron X-ray 
light at the Canadian Light Source, Saksastoon, SK, Canada on beamline 08ID-1 and 08BM-1, 
and at the Advanced Photon Source, Woodridge, IL, USA on beamline 17-ID-B. The presence of 
Se in crystals was assessed with X-ray fluorescence by scanning an X-ray energy spectrum +/- 
0.2 keV from the theoretical Se K edge (12.6 keV). For experimental phasing, single-wavelength 
anomalous diffraction (SAD) experiments were performed by diffracting crystals at 12.656 keV, 
an X-ray energy equal to the Se K edge and a complete 360° single-wavelength anomalous 
diffraction (SAD) dataset was collected for initial structure solution, using 720 images of width 
0.5°, an exposure time of 0.2 s per image, and a transmittance of 100%. Unlabelled crystals 
CHARACTERIZING BcsG                                                        46 
were diffracted with incident X-ray radiation with a wavelength of 1.0000 Å (12.398 keV) with 
the same collection parameters.  
Data processing and structure solution/refinement. Collected data were processed by 
indexing, scaling and integrating frames in the XDS and/or Mosflm software suites92. Processed 
SAD data was used to attempt structure solution using experimental phasing in the PHENIX 
software package93. The native structure was solved using molecular replacementwith the 
program PHASER93 using the Se-labelled structure as a search model94. Structural refinement 
was performed using iterative rounds of automated refinement using PHENIX93 followed by 
manual model building and refinement in Coot95. Refinement progress was monitored by 
following the reduction (and convergence) of the Rwork and Rfree. Visualization of the model was 
done in the PyMOL software package. The biological assembly of EcBcsGΔN was assessed using 
the PDBePISA server96. Metal content was assessed with the CheckMyMetal server97. 
Inductively coupled plasma – atomic emission spectroscopy. The metal content of EcBcsGΔN 
was determined using ICP-AES. EcBcsGΔN was purified as described in section 4.2 above in the 
absence of exogenous metals in the purification buffers. The analyzed samples were 
concentrated to 1 mM and digested in 200μL of HNO3 by heating at 70°C for 1 h until all 
EcBcsGΔN was dissolved. The sample was then passed through a 0.45 μm centrifugal filter and 
diluted to 50 μM EcBcsGΔN and 2% v/v HNO3 with 18 megohm-cm-1 purity water and analyzed 
for S, Mg, Co, Cu and Zn at two analytical wavelengths for each element (Mg: 285.213 and 
279.077 nm; Zn 206.200 and 213.857 nm; Cu 327.393 and 324.752 nm; Co 228.616 and 238.892 
nm) in a Perkin Elmer Optima 8000 ICP-AES. Prepared solutions of copper chloride, magnesium 
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chloride, zinc sulfate, and 2% (v/v) HNO3 were used as analytical standards and the blank, 
respectively.  
Molecular phylogenetics. The sequence of putative pEtN transferase genes described by 
Harper et al.63 were downloaded from the National Center for Biotechnology Information 
(NCBI) protein sequence database. Multiple-sequence alignments were performed using the 
constraint-based multiple alignment tool COBALT available at NCBI. For phylogenetic analysis, 
the alignment data were visualized with FigTree 1.4.3 (http://tree.bio.ed.ac.uk/). Structural 
homologues of EcBcsGΔN were queried using the DALI server98. 
5. Results and Discussion 
5.1 Expression and purification of EcBcsGΔN 
 
Expression of EcBcsGΔN. High yields of soluble EcBcsGΔN were observable in the cell lysate of E. 
coli BL21 (DE3) used as an expression host following culture and IPTG (1 mM) induction (Figure 
7) for 16 h at 23°C.  Protein yield following preliminary IMAC purification was routinely > 50 
mg/L of culture at near homogeneity (Figure 7; Lane 3), and did not warrant further 
optimization as yield and purity was sufficient for downstream applications. Purification to total 
Figure 8: SDS-PAGE of a typical EcBcsGΔN purification. Lanes 1: Ladder, Lane 2: cell lysate, Lane 3: IMAC 
elutions, Lane 4: IEC elutions. 
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homogeneity at high yield (> 45 mg / L of culture) was possible by secondary purification using 
either size exclusion chromatography or anion exchange chromatography (Figure 7; Lane 4). 
5.2 Crystallization of EcBcsGΔN 
 
Native EcBcsGΔN. Primary purification of EcBcsGΔN was performed by IMAC and secondary 
purification was performed by SEC or IEC to total homogeneity and concentrated to 45 mg/mL 
(1 mM) prior to the preparation of crystallization plates. Initial screening of the MCSG 1-4 
Crystallization Suites identified two lead conditions permissible to EcBcsGΔN crystal growth: 
MCSG4-G11 (0.1 M HEPES:NaOH pH 7.5, 20% (w/v) poly-(ethylene glycol) 4000, 10% (v/v) 2-
propanol) and MCSG4-F7 (0.2 M magnesium chloride, 0.1 M MES:NaOH pH 6.5, 25% (w/v) PEG 
4000). Further expansion screening of these conditions by altering the pH or concentrations of 
salts and precipitants failed to retain crystal growth and instead resulted in rapid EcBcsGΔN 
precipitation. Crystals of native EcBcsGΔN appeared to form optimally in the MCSG4-G11 
Figure 9: Representative EcBcsGΔN crystal size and morphology. Selenomethionine-labelled EcBcsGΔN 
crystals grew with rhomboid morphology, ranging from approximately 150 x 50 μm (A) to 30 x 50 μm (B). 
Native EcBcsGΔN crystals also grew with a rhomboid morphology, ranging from to 50 x 200 μm (C) to 50 x 
100 μm (D). 
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condition (0.1M HEPES:NaOH pH 7.5, 20% (w/v) poly-(ethylene glycol) 4000, 10% (v/v) 2-
propanol) when drops were prepared using EcBcsGΔN SEC buffer (20 mM Tris, 150 mM NaCl, 5 
mM MgCl2, pH 7.5) as the solvent for recombinant protein. The presence of Mg2+ was critical for 
crystal formation, as plates set up in the absence of Mg2+ did not display crystal growth 
following 8 weeks of incubation at 22°C. In the presence of Mg2+, crystal growth could be 
observed within 5-7 days of incubation as rod shaped crystals, ranging in size from 
approximately 30 x 50 μm to 50 x 200 μm. Ideal crystal growth was observed after 28 days of 
elapsed incubation, at which point cracking and damage to the crystalline lattice became 
evident.  
Seleno-L-methionine labelled EcBcsGΔN. Optimal crystal formation occurred for labelled 
EcBcsGΔN similarly to native EcBcsGΔN following purification by IMAC and SEC. Crystals of 
labelled enzyme grew readily in the MCSG4-G11 condition previously identified by high-
throughput screening, and crystal growth also appeared to be dependent upon the presence of 
Mg2+. Crystals appeared in the conditions tested after 7 days of incubation at 22°C and 
appeared to cease growth after 24 days of incubation. Large, highly ordered rod-shaped crystals 
were observed, similarly to crystals grown with native EcBcsGΔN, ranging in size from 
approximately 50 x 100 μm to 100 x 250 μm (Figure 8).  
5.3 The X-ray crystal structure of EcBcsGΔN 
 
Model quality. The de novo structure of EcBcsGΔN was determined using the single-wavelength 
anomalous diffraction (SAD) method with high-resolution (1.26 Å) anomalous scattering at the 
selenium K edge (12.656 keV, 0.979647 Å) on crystals prepared with uniformly L-
selenomethionine labelled EcBcsGΔN (herein EcBcsGΔN-Se). The diffraction experiment statistics 
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are available in Table 4. The high-resolution diffraction data were reduced and included 
reflections at a maximum resolution of 1.44 Å to ensure overall data quality as indicated by 
correlation coefficients (e.g. CC1/2 > 0.8). Model building and refinement improved the Rwork and 
Rfree from 0.212 and 0.229 to 0.197 and 0.212, respectively. Analysis of data suggested crystals 
grew in space group P 21 21 21 with the model containing two copies of EcBcsGΔN in the 
asymmetric unit, consistent with a Matthews coefficient of 2.09 and a solvent content of 
approximately 40%. However, we observed no evidence that EcBcsGΔN may form a dimer in its 
biological assembly during purification by size exclusion chromatography. The EcBcsGΔN model 
presented excellent stereochemical parameters (Table 4) and covers almost the entirety of the 
catalytic domain. The structure is complete at the C-terminus and truncates in an unstructured 
loop immediately adjacent to the His6-tag at the N-terminal region of the soluble domain. One 
copy of the protein in the asymmetric unit contains weak electron density about residues Ala484 
and Ala382, and so these residues could not be reliably built into the model. In the second copy, 
the fit of Ala484 and Ala382 to the density is satisfactory and the folding of EcBcsGΔN at these 
residues can still be inferred from this model. No Ramachandran outliers are present, and only 
16 residues (2.23%) lie outside the ideally preferred region and in the allowed regions. Only one 
(0.32%) side chain rotamer outlier, Phe359, is present, and only in one copy of the molecule. 
There are no obvious artefacts of crystallization, although small amounts of unmodelled density 
about the active site contribute to the residual statistics.  
 The completed structure of EcBcsGΔN labelled with L-selenomethionine was used as a 
molecular replacement search model to solve a dataset collected on an unlabelled native 
EcBcsGΔN crystal. The data collection and refinement statistics for the unlabelled crystal are also  
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Values in parentheses correspond to the highest resolution shell. I/σ(I): intensity of a group of reflections divided by the 
standard deviation of those reflections. Rmerge = ∑ |I(k) − <I>|/∑ I(k), where I(k) and <I> represent the diffraction intensity values 
of the individual measurements and the corresponding mean values. The summation is over all unique measurements. Rwork = ∑ 
||Fobs|− k|Fcalc||/|Fobs|, where Fobs and Fcalc are the observed and calculated structure factors, respectively. Rfree is the sum 
extended over a subset of reflections excluded from all stages of the refinement. 
Table 4: Diffraction data processing, refinement statistics, and model validation 
 
 EcBcsGΔN-Se EcBcsGΔN 
Resolution range (Å) 45.97  - 1.44 (1.491  - 1.44) 47.96  - 1.75 (1.813  - 1.75) 
Space group P 21 21 21   P 1 21 1 
Cell dimensions   
   a, b, c (Å) 78.71, 94.58, 105.19 52.51, 76.92, 95.92 
   α, β, γ (°) 90, 90, 90 90, 90.578, 90 
X-ray energy (eV) 12656.0 12398.4 
Total reflections 1832824 (181077) 520255 (43663) 
Unique reflections 142127 (14051) 74391 (6595) 
Multiplicity 12.9 (12.9) 7.0 (6.6) 
Average I/σ(I) 19.13 (2.64) 28.56 (7.42) 
Completeness (%) 99.99 (99.99) 96.64 (85.96) 
Anomalous completeness (%) 99.87 N/A 
Rmerge 0.07407 (1.063) 0.0435 (0.2657) 
Rmeas 0.7719 (1.108) 0.04711 (0.2894) 
Rpim 0.02148 (0.3069) 0.01794 (0.1126) 
CC1/2 0.999 (0.773) 0.999 (0.969) 
CC* 1 (0.934) 1 (0.992) 
   
Refinement statistics   
Reflections used in refinement 142124 (14051) 74372 (6577) 
Reflections used for R-free 7107 (703) 3719 (329) 
Rwork 0.197 (0.272) 0.161 (0.214) 
Rfree 0.212 (0.311) 0.198 (0.236) 
CC(work) 0.957 (0.828) 0.965 (0.860) 
CC(free) 0.953 (0.760) 0.951 (0.789) 
Number of non-H atoms   
               Total 6362 6742 
               Macromolecules             5657 5706 
               Ligands 3 3 
               Solvent 702 1033 
Protein residues 725 732 
RMS bond lengths (Å) 0.007 0.007 
RMS bond angles (°) 1.24 1.03 
Ramachandran favoured (% ; #) 97.77 ; 709 97.39 ; 713 
Ramachandran allowed (% ; #) 2.23 ; 16 1.79 ; 13 
Ramachandran outliers (% ; #) 0.00 ; 0 0.82 ; 6 
Romater outliers (%) 0.32 ; 1 0.32 ; 1 
Clashscore 1.62 9.61 
Average B-factor   
               Total 23.9 23.5 
               Macromolecules 22.8 21.7 
               Metal ions 16.3 19.0 
               Solvent 32.4 33.2 
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 listed in Table 4. A P 21 space group resolved to 1.75 Å with packing on an alternate face is 
observed, although two copies are still present in the asymmetric unit. Refinement of the 
native structure resulted in an improved Rfree and Rwork of 0.161 and 0.198, respectively.  The 
model also covers the entire C-terminal catalytic domain, with truncation at the N-terminus 
near the His6 tag. Similar stereochemical parameters are observed in the native structure, 
indicating a high-quality model of EcBcsGΔN. The same single rotamer outlier, Phe359 is present. 
Six (0.82%) Ramachandran outliers are present, with thirteen (1.79%) residues lying outside the 
preferred regions. No obvious artefacts of crystallization were observed in this model. 
The overall fold of EcBcsGΔN. The crystal structure of EcBcsGΔN reveals a three-dimension al fold 
bearing 15 α-helical and 13 β-sheet secondary structure elements (Figures 10 and 11). A 7-
stand β sheet is present at the core of the protein, flanked by five α helices. Both a large α-
helical component and a small 3-strand antiparallel β-sheet are present at the N-terminal 
region of the fold, presumably oriented towards the inner membrane in vivo, based on the 
predicted orientation of the N-terminal region of EcBcsGΔN and its similarity to predicted 
homologues. The structure truncates in a loop, presumably the linker between the catalytic 
domain and the N-terminal transmembrane domain. 
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5.4 EcBcsG is a member of the pEtN transferase family.  
 Structural homology. Our results show that the soluble, periplasmic domain of BcsG 
folds in a globular structure that is typical of the alkaline phosphatase superfamily. A structural 
homology search on the Dali server98 showed EcBcsGΔN belongs to a family of sulfatases, 
lipotechoic acid synthetases, and phosphatidyl-ethanolamine transferases. Among the highest 
scoring results are EptC from Campylobacter jejuni (CjEptC, PDB ID 4TN0), EptA from Neisseria 
meningitidis (NmEptA, PDB ID 4KAY), and the mobile colistin resistance factor 1 MCR-1 (PDB ID 
5K4P) with z-scores of 20.4, 20.2, 20.4 and 20.2, respectively. A review of the literature reveals 
Figure 10: Secondary structure topology cartoon of the overall fold of EcBcsGΔN. The overall topology 
shows the (β/α)7 fold typical for the alkaline phosphatase superfamily. α-helices are coloured cyan and 
β-sheets are coloured purple. The N- and C-terminus are denoted as N and C, respectively. Figure 
generated with TOPDRAW. 
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all three of these top structural homologues function as phosphoethanolmine (pEtN) 
transferases, using membrane phosphatidyl-ethanolamine as donor and decorating lipid A-Kdo2 
with phosphoethanolamine64,65,72,77 and belong to a family of related enzymes that have been 
referred to as the pEtN transferase family73.  
 Using PyMOL, a Cα structural superposition of EcBcsGΔN with these structures resulted in 
an average alpha-carbon r.m.s.d. of 2.953 Å across 173 equivalent Cα atoms (Fig. 12). Among 
the highest regions of conservation in folding architecture are four loops adjacent to the core β-
sheet of all structures tested. These loops contribute residues to the active site of the pEtN 
transferase family and suggest that the active site of EcBcsG may also be comprised of these 
folds.  A subsequent amino acid sequence alignment of EcBcsGΔN, MCR-1, CjEptC, and NmEptA 
revealed several blocks of conserved residues among these structures, although the alignment 
was generally poor due to low sequence identity of EcBcsG and structural features had to be 
Figure 11: The overall fold of EcBcsGΔN. The structure is rendered as an α-carbon backbone trace with 
secondary structure element cartoons. α-helices are coloured cyan, β-sheets are coloured purple, and 
loops are coloured salmon. The solvent-accessible surface is rendered gray with a solvent radius of 0.5 
nm. Rendered using PyMOL. 
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manually aligned. The complete sequence alignment is available in Appendix 1 – Figure A8. Not 
surprisingly, these blocks of conservation are contained within the structurally similar loops of 
these enzymes (Fig. 12). However, some residues that contribute to the active site of NmEptA, 
CjEptC, and MCR-1 do not appear conserved in EcBcsGΔN, and suggest divergent evolution of 
EcBcsG from these structures, likely owing to their activity on lipid A, a vastly different 
substrate. Metal coordination in the active site of the MCR-1 like family is achieved by aspartic 
acid, glutamic acid, histidine, and a threonine residue – observed as phosphothreonine in the 
structures of MCR-1, CjEptC and NmEptA. Equivalents to the glutamic acid and histidine of 
other known pEtN transferases are present in EcBcsGΔN as residues Glu442 and His443. Cys243 and 
Ser278 in EcBcsGΔN are both positioned near these residues and may instead serve as equivalent 
to the metal-binding functions of the glutamic acid and threonine of the other pEtN 
Figure 12: A structural superposition of EcBcsGΔN with the homologous phosphoethanolamine 
transferases MCR-1, CjEptC and NmEptA. Significant folding similarity is observed, particularly across 
four loops that line the active site pocket of the EcBcsGΔN homologues. The amino acid sequence 
alignment of these loops is shown in blocks 1-4 (inset). Residues highlighted in red are involved in metal 
binding or catalysis. 
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transferases, and the hydroxyl of Ser278 may also be phosphorylated in a fashion analogous to 
CjEptC and NmEptA. Additionally, proton abstraction from the catalytic threonine is proposed 
to be accomplished by the metal-adjacent glutamic acid in the pEtN transferse family72. 
However, despite these amino acid equivalents that may plausibly serve catalytic roles in 
EcBcsG, the mechanism is unclear from the structure of the holoenzyme alone. 
Molecular Phylogenetics. Harper et al. reconstructed the molecular phylogeny of known and 
predicted pEtN transferases and showed the family contains distinct subfamilies, clustered 
based upon the substrate to which the enzyme transfers the pEtN group63. Known substrates 
for which pEtN transferases have specificity include the 6’OH of the lipopolysaccharide inner 
core Heptose II99, the 3’ OH of lipopolysaccharide inner core Heptose II99, various positions of 
the lipopolysaccharide outer core Gal63, the 1’ phosphate of lipid A72,77, various periplasmic or 
extracellular proteins63,74, and various periplasmic glycans, including the osmoregulated 
periplasmic glucan (OPG) in E. coli100 and the periplasmic protein N-linked glycan in C. jejuni101. 
Figure 13: The conserved pEtN transferase active site. The catalytic fold is comprised of a conserved His-
Asp-Glu Zn2+-binding triad, a catalytic phospho-threonine nucleophile, and conserved histidine, as 
demonstrated from representative structures of lipid A pEtN transferases (B). EcBcsG (A) contains an 
unusual active site for the family, shaped by a Cys in place of the Zn2+ binding Glu, and a serine catalytic 
nucleophile. 
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To date, all available structures of the pEtN transferase family are limited to those belonging to 
the subfamily specific for the 1’ phosphate of lipid A. Furthermore, Stogios and colleagues73 
constructed a sequence-based phylogenetic analysis of the enzymes belonging to this subfamily 
specific for the 1’ phosphate of lipid A and found that the subfamily further contains sequence 
dissimilarity with at least four major clades73. Although the membership of EcBcsG to the pEtN 
transferase family is apparent from its structural homology to the lipid A transferases, its 
placement within the family is unclear due to the limited number of available structures, of 
which all belong to the subfamily with substrate specificity for lipid A. To address the 
relationship of EcBcsG to the other pEtN transferase family members, a sequence-based phylo-
genetic analysis was performed with a sequence-based alignment using COBALT and visualized 
as a maximum-likelihood tree using FigTree (Fig. 14). The phylogenetic analysis was based on 
the known and predicted pEtN transferase family members compiled by Harper et al.63 using 
sequence data available from repositories and was updated to include EcBcsG. The EcBcsG 
sequence aligned poorly to other known and predicted pEtN transferases and clustered 
independently, which was not surprising given the divergence of residues in EcBcsG that are 
otherwise strictly conserved in the pEtN transferase family. The phylogenetic analysis suggests 
that BcsG belongs to a novel subfamily of phosphoethanolamine transferases which cluster 
near to pEtN transferases with specificity for the C6 hydroxyl of lipopolysaccahride Heptose II. 
This is interesting given that the proposed regioselectivity of EcBcsG is for the C6 hydroxyl of a 
hexose. 
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Figure 14: Phylogenetic analysis of representative known and predicted pEtN transferases based on 
Harper et al. Shaded clusters represent subfamilies that share substrate specificity as follows; pink, 
transferases specific for 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) residues of lipopolysaccharide; 
green, transferases specific for the C6 OH of Heptose II residues of lipopolysaccharide; gray, transferases 
specific for the C3 OH of Heptose II residues of lipopolysaccharide; yellow, transferases specific for the 
outer core Gal residues of lipopolysaccharide; blue, transferases specific for the 1’ phosphate of lipid A. 
Bacterial species names are listed in sequence annotations of the tree as follows; Acti.p, Actinobacillus 
pleuropneumoniae; Aero.s, Aeromonas salmonicida; Aggr.a, Aggregatibacter actinomycetemcomitans; 
Bp, Bordetella pertussis; Cj, Campylobacter jejuni; Ec, Escherichia coli; Hd, Haemophilus ducreyi; 
Hf, Haemophilus felis; Hh, Haemophilus haemolyticus; Hi, Haemophilus influenzae; Hp, Helicobacter pylori; 
Mh, Mannheimia haemolytica; Ng, Neisseria gonorrhoeae; Nm, Neisseria meningitidis; Pm, Pasteurella 
multocida; Sf, Shigella flexneri; Shew.p, Shewanella putrefaciens; ST, Salmonella 
enterica subsp. enterica serovar Typhimurium; Vc, Vibrio cholerae; Vh, Vibrio harveyi; Vp, Vibrio 
parahaemolyticus. Generated with FigTree. 
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Metal-binding sites. Metal-dependency is typical for the alkaline phosphatase superfamily, 
although the physiological metal and the coordination environment of superfamily members 
varies widely102. A survey of structurally resolved members of the pEtN transferase family 
demonstrates dependency on Mg2+, Zn2+, or a combination of these. Because of the overall 
EcBcsGΔN fold typical of metal-dependent members of the alkaline phosphatase superfamily, 
similarity to the pEtN transferase family, and the apparent stabilizing effect of including Mg2+ in 
purification and crystallization conditions, the structure of EcBcsGΔN was surveyed for sites in 
which Mg2+ might bind. In the putative EcBcsGΔN active site, the top of helix 6 (residues 278-
286) and three loops protruding from the top of β strands 18, 16, and 2 fold into a solvent-
accessible pocket. The side chains of Cys243, Ser244, Ser278, His396, Glu442, and His443 face in 
towards this pocket (Fig. 14). A large peak detectable > 7 σ in the Fo-FC map was calculated in 
this pocket and was not attributable to the EcBcsGΔN macromolecule, observed adjacent the 
side chains of Cys243 Ser278, Glu442, and His443 in a tetrahedral geometry, suggesting that a ligand 
Figure 15: The Fo-Fc map contoured at 7 σ about the putative active site of EcBcsGΔN. A large positive 
difference peak in the Fo-Fc map suggests a metal ligand is bound here. 
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is bound here (Figure 15). Surprisingly, placement of either a Mg2+ ion or a water molecule into 
this electron density refined poorly and suggested a poor fit to the diffraction data.  However, a 
second site at which electron density suggests another ligand-binding site is observed 
elsewhere in the resolved structure of EcBcsGΔN. A second large Fo-Fc peak was calculated 
adjacent to the amide nitrogen of Thr478 and Asn483, and the side chain of Asp481 (Figure 16). 
This second ligand site is also coordinated by three highly ordered water molecules in an 
octahedral arrangement. Occupancy of this site with Mg2+ (present from the crystallization 
conditions) into this density refined optimally and suggested a good fit of this ligand with the X-
ray diffraction data. In the second copy of EcBcsGΔN present in the asymmetric unit, however, 
this electron density was not observed and the local folding near this site differs from the 
ligand-bound state. These observations suggested that Mg2+ likely plays a role in EcBcsGΔN 
folding in this local region and accounted for the stabilizing effect of magnesium salts during 
purification and crystallization of EcBcsGΔN. 
Figure 16: The Fo-Fc map contoured at 7 σ about the secondary metal-binding site. A strong calculated 
electron density peak is observed bound to D481, N483 and T478, likely a Mg2+ ion. 
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To further investigate the identity of the ligands at these two binding sites, the structure 
of EcBcsGΔN was uploaded to the CheckMyMetal server97 (https://csgid.org/metal_sites). The 
results suggest the ligand environment of the secondary ligand site (D481/483/478) is typical of 
Mg2+ binding sites for all parameters tested and provides further evidence that the identity of 
the secondary site ligand is in fact Mg2+. This analysis also confirmed skepticism that the active 
site (C243/S278/E442/H443) ligand may also be Mg2+, as tetrahedral geometry is not typical for 
Mg2+ ligands and Mg2+ was also a poor fit to the local B factor and bond-valence parameters of 
the crystal in this region (Fig. 17). Instead, the results suggested a ligand environment in the 
active site more typical of Co2+, Cu2+, or Zn2+, although no clear preference was observed. 
Further refinement of the resolved EcBcsGΔN structure with all three of these metal ions as 
ligands in active site resulted in an equally good fit to the experimental data and did not further 
suggest the identity of the physiological ligand. To unambiguously identify the ligand in the 
putative active site, EcBcsGΔN was purified in the absence of exogenous metal ions using buffers 
prepared with 18 megaohm cm-1 water and was digested in HNO3 for analysis by ICP-AES. The 
EcBcsGΔN elemental spectra for Zn2+, Cu2+, Co2+ and Mg2+ unambiguously confirm the identity of 
the ligands observed by X-ray diffraction (Figure 18). A strong analytical signal, > 40-fold above 
Figure 17: Output from the CheckMyMetal server. Site ID 1 is the active site and site ID 3 is the 
secondary site. 
CHARACTERIZING BcsG                                                        62 
the blank for Mg2+ and > 90-fold for Zn2+ was observed, while weak signal intensities for Cu2+ 
and Co2+ were observed, approximately 1.5-fold and 4-fold above the blank, respectively. 
Further analysis of analytical standards of 10 μM Zn2+ and 15 μM Cu2+ further confirm that the 
Cu2+ and Co2+ levels represent negligible quantities, while Zn2+ and Mg2+ are present in sufficient 
quantities to conclude that they must comprise the observed ligands in the structure of 
EcBcsGΔN. Concurrently, crystals of EcBcsGΔN were analyzed by X-ray fluorescence (XRF) 
spectroscopy near the K edge for Mg (1.3050 keV), Zn (9.6586 keV), Cu (8.9789 keV), and Co 
(7.7089 keV) and confirmed the presence of Mg and Zn in EcBcsGΔN crystals.  Final refinement of 
the structure of EcBcsGΔN was completed with these ligand sites occupied by Zn2+ and Mg2+. 
Internal disulfide bond. While the number of total disulfide bonds identified varies from 
three (CjEptC and MCR-1) to five (NmEptA) in the pEtN transferase structures examined here, 
only a single conserved disulfide bond, separated by 10 amino acids, is shared by all three of 
these structures65,72,77. This disulfide bond is shaped by the conserved cysteine pairs Cys262-
Cys272 in CjEptC, Cys281-Cys291 in MCR-1, and Cys276-Cys286 in NmEptA (Figure 18) 65,72,77. 
Figure 18: ICP-AES emission spectra at analytical wavelengths for Mg, Zn, Cu and Co. A strong emission 
singal was observed for Mg and Zn, but not for Cu or Co. Emission of the analytical standards suggest 1 
equivalent of Mg and Zn per polypeptide chain.  
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The conserved disulfide bond directly fixes the helical secondary structural elements of 
NmEptA, CjEptC and MCR-1, which contribute the respective catalytic threonine nucleophiles, 
to the loops immediately N-terminal of each helix 65,72,77. These conserved disulfides thus orient 
the catalytic nucleophiles in close proximity to the Zn2+ ion present at the respective catalytic 
centers. Recently, the structure of EcEptC (PDB ID 6A83) was reported to have an overall similar 
fold and share structural similarity with the pEtN transferase family66. However, EcEptC did not 
confer polymyxin resistance in vivo despite sharing the conserved active site architecture and 
catalytic Zn2+ binding discussed here66. Instead, Zhao et al.66 proposed that the absence of Cys 
pairs forming disulfides in EcEptC was responsible for the lack of observed activity, and showed 
that disruption of Cys pairs in MCR-1 or CjEptC also abrogated polymyxin resistance when 
expressed in E. coli C43 to levels observed with expression of EcEptC66.  
 To understand the importance of disulfide bond presence in EcBcsG, the 
structure was examined for the presence of the conserved disulfide bond. The equivalent 
amino acids to the conserved cysteine pairs from CjEptC, NmEptA and MCR-1 described above 
are observed as Ala274 and Arg284 in EcBcsGΔN. Instead, an unambiguous disulfide bond was 
observed in both the native and Se structures of EcBcsGΔN between the cysteine pair Cys290-
Cys306, spaced instead by 16 amino acids (Figure 19). This unusual disulfide bond in EcBcsG 
appears to serve the same function as the conserved pEtN transferase disulfide bond, despite 
being structurally distinct. Instead of fixing the helix presenting the catalytic nucleophile to a 
loop directly N-terminal to it, the EcBcsG disulfide instead links the loop immediately C-terminal 
of the equivalent helix with a neighbouring helical element packed against the central beta-
sheet fold. This novel disulfide retains the conserved structural features related to their 
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proposed function; orienting the catalytic EcBcsG nucleophile, Ser278, in proximity to the 
catalytic Zn2+ of the EcBcsGΔN active site in an analogous fashion to CjEptC, NmEptA and MCR-1. 
 
Polymyxin Susceptibility Assay. Several members of the pEtN transferase family have been 
described to transfer pEtN to both lipid A and other secondary substrates, including the C. jejuni 
periplasmic N-linked glycan101, flagellins77, pilins15,74, and likely other diverse periplasmic 
targets. To assess if EcBcsG retains activity on lipid A in vivo, the susceptibility of E. coli AR3110 
and E. coli AR3110 ΔbcsG to the antimicrobial peptides polymyxin E (colistin) and polymyxin B 
were assessed using a minimum inhibitory concentration (MIC) assay. The observed MIC of 
Figure 19: The pEtN transferase disulfide bond. A conserved, disulfide bonded cysteine pair in CjEptC 
(green), MCR-1 (magenta), and NmEptA (orange) fixes the helix presenting the catalytic threonine 
adjacent to the catalytic Zn2+ at the active site and is important for activity. In EcBcsGΔN (cyan), a similar 
disulfide is observed, although not at the conserved location. Figure rendered in PyMOL. 
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colistin was 2 μg/mL in both AR3110 and E. coli AR3110 ΔbcsG, in agreement with colistin-
susceptible E. coli isolates that do not possess intrinsic or acquired colistin resistance (Figure 20) 
103. The polymyxin B MIC was observed to be 4 μg/mL for E. coli AR3110 and 8 μg/mL for E. coli 
AR3110 ΔbcsG. Furthermore, visible quantities of biofilm were present in the microtiter plate at 
the time of analysis, confirming the conditions of the assay were biofilm-permissive. Our 
findings did not support the hypothesis that EcBcsG retains activity on lipid A in vivo to confer 
intrinsic polymyxin resistance, since EcBcsG expression was not correlated with colistin MIC. 
5.4 Functional complementation of EcBcsG 
 
Pellicle assay. The colony morphotype of E. coli K-12 and S. enterica UMR1, and nonpolar bcsG 
chromosomal mutant derivatives thereof, have been described previously as a reporter for 
BcsG activity when grown on semisolid media containing Congo Red104. However, bcsG deletion 
mutants were observed to produce cellulose and, thus, retain a red, dry and rough morphotype 
using this assay. As a result, the colony morphotype of E. coli bcsG deletion strains producing 
unmodified cellulose was indistinguishable from that of the wild-type E. coli strains producing 
Figure 20: Colistin and polymyxin B minimum inhibitory concentration assay. Growth under biofilm-
permissive conditions did not induce intrinsic polymyxin reistance in E. coli AR3110, nor did nonpolar 
deletion of bcsG in E. coli AR3110 induce polymyxin susceptibility. 
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pEtN cellulose. To detect the phenotypic consequences of loss of bcsG function, a robust assay 
was developed to distinguish the functional contribution of bcsG and, thus, pEtN cellulose to 
the E. coli K-12 biofilm phenotype. Our results recapitulate those by Thongsomboon et al.32 and 
demonstrate that the pEtN modification conferred by EcBcsG activity on cellulose is essential 
for the E. coli AR3110 extracellular matrix assembly and architecture. The wild-type cellulose 
producing strain E. coli AR3110 produced a rigid pellicle that formed a cohesive, tissue-like layer 
when grown in salt-free LB broth that adhered to solid surfaces and was resistant to mechanical 
stress (Figure 21). The nonpolar chromosomal bcsG mutant in the E. coli AR3110 background 
(AR3110 ΔbcsG) produced a similar pellicle morphotype, although the biofilm did not display 
the same cohesive properties and was completely disrupted upon subjection to mechanical 
stress. Functional complementation of the AR3110 ΔbcsG cell line with the pET28a-encoded, 
full-length recombinant bcsG construct restored the rigid, self-assembling properties of the 
extracellular matrix, while complementation with the C-terminal catalytic domain or the vector 
alone failed to restore these properties and their biofilms were mechanically disrupted with 
ease, demonstrating that full-length EcBcsG is both necessary and sufficient for pEtN cellulose 
and, thus, the rigid pellicle phenotype observed in this experiment. 
Figure 21: The pEtN cellulose pellicle assay. The rigid pellicle phenotype of E. coli AR3110 is lost upon 
deletion of bcsG and is rescued only by complementation with pBcsG, but not pBcsGΔN or the pET28a 
plasmid. Pellicles were stained in 0.01% (w/v) Congo Red following isolation from cultures and visualized 
with a BioRad VersaDoc 4000. 
CHARACTERIZING BcsG                                                        67 
Crystal Violet Adherence Assay. A semi-quantitative analysis of the adherence potential of 
these phenotypes was performed using a crystal violet static biofilm assay, and the adherence 
potential appeared to follow the pellicle phenotype assayed above (Figure 21). Comparison of 
the AR3110 cell line to its ΔbcsG derivative suggested that loss of bcsG results in the loss of 
adherence potential by the biofilm, easily removed from the growth surface by gentle washing 
in phosphate buffered saline. The AR3110 cell line demonstrated > 4-fold higher crystal violet 
staining than the nonpolar bcsG mutant, restored by functional complementation with bcsG, 
but not bcsGΔN or the vector alone.  
Site-Directed Mutants. To map the active site of EcBcsG and elucidate the function of key 
residues identified in its structure, site-directed mutants of the full-length recombinant EcBcsG 
were generated and their sufficiency to rescue the fragile pellicle phenotype of the E. coli 
AR3110 ΔbcsG cell line were assessed using the pellicle (Figure 23) and static crystal violet 
Figure 22: Crystal violet adherence of pellicle biofilms. The adherence potential of E. coli AR3110 is lost 
upon deletion of bcsG and was rescued only by complementation with pBcsG, but not pBcsGΔN or the 
pET28a plasmid. Asterisks denote significantly different groups (p < 0.05, Welch test) 
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assays (Figure 2r). Protein variants of EcBcsG, supplemented to E. coli AR3110 ΔbcsG in trans, 
containing single alanine substitutions in amino acids Cys243, Ser278, Glu442, His443, His396, and 
Tyr277 failed to functionally complement the chromosomal bcsG deletion, and resulted in the 
growth of fragile pellicle that was sensitive to mechanical disruption (Fig. 22). A Tyr277Phe 
protein variant was also constructed by mutagenesis of pBcsG to assess if Tyr277 is involved in 
substrate accommodation of cellulose, noted as a possibility based on its position in the crystal 
structure. To our surprise, the Tyr277Phe mutation also did not rescue the fragile pellicle 
phenotype of E. coli AR3110 ΔbcsG, suggesting that the tyrosine hydroxyl may instead be 
involved in forming polar contacts with substrate, rather than through ring-stacking 
interactions. Additionally, the Phe329Ala protein variant rescued the fragile pellicle phenotype of 
E. coli AR3110 ΔbcsG, also suggesting that ring-stacking interactions by both aromatic residues 
lining the predicted active-site pocket do not function in substrate-binding or catalysis by 
EcBcsG. 
 To further investigate the hypothesis that the observed disulfide bond is important for 
catalytic activity of EcBcsG, a disulfide-deficient variant, EcBcsG C290A C306A, was constructed 
and assessed for its activity in vivo using the functional complementation experiment. The 
Figure 23: Pellicle assay data for EcBcsG amino acid variants. Alanine substitutions of Cys243, Ser278, 
Glu442, His443, or Tyr277 fail to rescue the fragile pellicle phenotype, while an alanine substitution in Phe329 
did rescue the fragile pellicle phenotype. A further Tyr277Phe substitution failed to rescue the fragile 
pellicle phenotype. 
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results demonstrated that the EcBcsG C290A C306A did not functionally complement E. coli 
AR3110 ΔbcsG and failed to rescue the fragile pellicle phenotype. This data suggests that the 
disulfide is indispensable for catalytic activity in vivo, and disruption of this disulfide results in a 
phenotype indistinguishable from EcBcsG variants with disruptions in the essential catalytic 
architecture. This indispensability of the disulfide bond corroborates the role of this disulfide as 
a mimic of the conserved disulfide in the other pEtN transferases discussed here despite its 
alternate position in the structure. 
 
Figure 24: Crystal violet assay data for EcBcsG amino acid variants. Alanine substitutions of Cys243, Ser278, 
Glu442, His443, or Tyr277 fail to rescue the adherence potential of E. coli AR3110 ΔbcsG, while an alanine 
substitution in Phe329 did rescue the adherence potential. A further Tyr277Phe substitution failed to 
rescue the adherence potential. 
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Mutant Expression. A Western immunoblot of prepared E. coli AR3110 ΔbcsG cell lysates (30 μg 
total protein/well) supplemented with wild-type and variant pBcsG demonstrated invariable 
expression of bcsG and its variants from the pBcsG plasmid in trans at low, but detectable, 
levels indicating that differences in pellicle phenotype of these cell lines are attributable to 
differences in their amino acid composition and not their differential expression (Figure 25). 
 
5.5 Functional bioassay 
 
 Synthesis of p-NPPE. Repeated screening and analysis of various commercially available 
substrate analogs failed to detect enzymatic product from EcBcsGΔN . Substrates tested include 
O-phosphorylethanolamine (Sigma), 1-myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine 
(14:0 LysoPE, Avanti), deoxyguanosine triphosphate, deoxycytosine triphosphate, 
deoxyadenosine triphosphate, deoxycytosine triphosphate, and various cellulose analogs, such 
as Avicel® PH-101, hydroxyethylcellulose, and carboxymethyl cellulose. A review of the 
literature revealed that at least one other member of the pEtN transferase family, MCR-1, was 
capable of using the synthetic compound para-nitrophenyl phosphoethanolamine (p-NPPE), 
and that its synthesis was possible from commercially available starting materials. We 
Figure 25: Western immunoblot against the recombinant His-tag of cell lysates from the functional 
complementation experiments. Uniform expression is observed across the wild-type and amino acid 
variants. 
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attempted the synthesis of p-NPPE as described by Dimitrijevic and colleagues105 and 
successfully isolated the synthetic product, p-NPPE trifluoroacetate, as a fine white crystalline 
powder through the work of colleague (Lana Hiscock) in Dr. Maly’s laboratory (Wilfrid Laurier 
University). The organic product was structurally analyzed by 1H, 13C, 19F and 31P NMR 
spectroscopy and IR spectroscopy (Appendix 1). Quality control of p-NPPE was prepared by 
dissolving the p-NPPE trifluoroacetate in 10 M NaOH and performing an absorbance spectral 
scan and the λmax was found to be 414 nm (Appendix 1). This value was used for all further 
functional bioassay experiments utilizing p-NPPE. A standard curve of base-hydrolyzed p-NPPE 
was performed and compared to an analytical reference standard of paranitrophenolate 
(Sigma). No significant difference was detected between the reference standard and the p-
NPPE we prepared (Appendix 1), and so it was deemed suitable for downstream analysis with 
EcBcsGΔN. 
Activity of EcBcsGΔN. To test EcBcsGΔN  activity, the enzyme was overloaded with substrate at 
levels described by Wanty and colleagues for MCR-1 (i.e. 5 mM)65. Incubation of EcBcsGΔN with 
the chromogenic substrate p-NPPE resulted in the release of the para-nitrophenolate ion giving 
a strong absorbance at 414 nm at a rate significantly higher than an enzyme-free control (t-test, 
p < 0.05, Figure 26). To test if EcBcsGΔN was capable of transferase activity in vitro, an identical 
reaction to the one described above was performed with the addition of 1 mM of either D-
glucose (Sigma), β-D-cellobiose, β-D-cellotriose, β-D-cellotetraose, β-D-cellopentaose, or β-D-
cellohexaose (Megazyme). Under conditions containing 1 mM of β-D-cellotetraose, β-D-
cellopentaose, or β-D-cellohexaose, a significant increase in the rate of formation of the para-
nitrophenolate ion was observed in a length-dependent fashion (Figure 27). To then test the 
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substrate specificity of EcBcsGΔN for cellulose, further transferase assays were performed with 
the addition 1 mM β-D-chitobiose, β-D-chitotriose, β-D-chitotetraose, β-D-chitopentaose, or β-
D-chitohexaose. No significant increase in the rate of formation of the para-nitrophenolate ion 
was observed in the presence of any of these chitooligosaccharides as compared to an 
acceptor-free control reaction (Figure 27).  
Figure 26: Phosphoethanolamine transferase assay. The rate of para-nitrophenolate formation in the 
presence of EcBcsGΔN was increased in the presence of celloligosaccharides 4 residues or longer, and in a 
length-dependent fashion (left). No such increase was observed with chitooligosaccharides (right). 
Letters denote statistically significant groupings (ANOVA, p > 0.0001). 
Figure 27: EcBcsGΔN liberates para-nitrophenolate from p-NPPE. A significantly increase in the rate of p-
NPPE cleavage and para-nitrophenolate formation was observed in the presence of 50 μM EcBcsGΔN. 
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In an effort to detect the enzymatic product, both the reaction condition containing 
cellopentaose and an enzyme-free control were repeated for a 24 h duration. The resulting 
reaction mixtures were spotted on a silica plate for analysis by thin-layer chromatography. 
Following separation, staining of the silica matrix revealed a shift in the retention of the 
carbohydrate component of the reaction mixture following treatment with EcBcsGΔN (Fig. 28).  
To confirm the increase in the rate of turnover of p-NPPE was the result of transferase activity, 
the reaction products from the sample containing cellopentaose were then separated and 
analyzed by LC-MS to confirm the transfer of the pEtN group. Along with unreacted p-NPPE 
([C8H12NO6P]+H+, m/z 263.1614) and cellopentaose ([C30H52O26]+H+, m/z 829.2814), there was 
Figure 28: Thin-layer chromatography of the EcBcsGΔN product. Cellopentaose (1 mM) in the presence of 
p-NPPE (5 mM) has a high retention time in the nonpolar mobile phase (left) that is reduced by 
treatment with 50 μM EcBcsGΔN  (right). TLC plate was stained in a 3% (w/v) α-napthol dissolved in 25:3:2 
methanol:water:sulfuric acid solution. 
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observed a new species with a novel m/z corresponding to the expected molecular weight of 
the monosubstituted pentamer ([C32H58NO29P]+H+, m/z 952.2892: Fig. 29). Such a species was 
absent in an enzyme-free control, which instead contained only the m/z species corresponding 
to the starting materials. 
 
Rate kinetics. To measure the apparent kinetic parameters of EcBcsGΔN using the in vitro assay 
described here, the apparent initial enzymatic rate was measured at varying concentrations of 
p-NPPE using a fixed concentration of 1 mM cellopentaose, and vice versa. Variation of p-NPPE 
from 0-10 mM and curve fitting (Fig. 30) of the subsequent initial rates as a function of 
substrate concentration resulted in an apparent Km of 1.171 ± 0.267 mM, maximal rate (Vmax) of 
5.728 ± 0.345 nmol min-1 mg-1, and kcat of 1.91 x 10-6 ± 1.15 x 10-7 s-1. The derived catalytic 
efficiency kcat/Km was 1.63 x 10-3 ± 3.84 x 10-4 M-1 s-1. The experiment was repeated at a fixed 
concentration of 5 mM p-NPPE (approximately 3x the Km) and cellopentaose concentration 
varying from 0 to 2.5 mM cellopentaose in 0.25 mM increments. Curve fitting of the measured 
initial rates as a function of substrate concentration resulted in an apparent Km of 1.435 ± 0.632 
Figure 29: The EcBcsGΔN enzymatic product mass spectra. Two nominal m/z species corresponding to 
mono-pEtN substituted cellopentaose were observed in the presence of EcBcsGΔN. 
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mM, Vmax of 12.27 ± 2.67 nmol min-1 mg-1, and kcat of 4.09 x 10-6 ± 8.86  x 10-7. The derived 
catalytic efficiency kcat/Km was then 2.4 x 10-3 ± 7.00 x 10-4 M-1 s-1. However, this model did not 
account for considerable rate of esterase activity observed of EcBcsGΔN (i.e. transfer to water 
rather than cellopentaose). To better model the kinetic behaviour of EcBcsGΔN under varied 
acceptor cosubstrate concentrations, the initial rates were corrected to discount the 
contribution of esterase activity against p-NPPE and the resulting initial rates were fit to a 
sigmoidal model (Figure 30). The model parameters were in good agreement with the p-NPPE 
kinetic values, with a calculated K1/2 of 1.701 ± 0.332, Vmax of 8.219 ± 1.435 nmol min-1 mg-1, and 
Hill slope of 1.877 ± 0.371. The kinetic parameters are summarized below in Table 5.  
Table 5: Measured kinetic parameters of EcBcsGΔN 
 Km/K1/2 (mM) Vmax (nmol min-1 mg-1) kcat (s-1) kcat/Km (M-1 s-1) 
p-NPPE 1.171 ± 0.267 5.728 ± 0.345 1.91 x 10-6 ± 1.15 x 10-7 
 
1.63 x 10-3 ± 3.84 x 10-4 
Cellopentaose 1.701 ± 0.332 8.219 ± 1.435 *4.09 x 10-6 ± 8.86  x 10-7 *2.4 x 10-3 ± 7.00 x 10-4 
* Based on ambiguous fitting to Michaelis-Menten model  
Figure 30: Curve fitting of EcBcsGΔN kinetic parameters. The specific EcBcsGΔN activity with varying p-NPPE 
(left) or cellopentaose (right) at a fixed concentration of cosubstrate were fit to Michaelis-Menten and 
sigmoidal models, respectively. 
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Amino Acid Replacements. To assess the catalytic consequences of amino acid substitutions 
within the EcBcsG active site, a library of amino acid EcBcsGΔN variants was constructed with 
substitutions of active site residues we observed to be essential for catalytic activity in vivo. All 
of the constructs used in this study, C243A, Y277F, S278A, H396A, E442A, and H443A were 
generated using site-directed mutagenesis of pBcsGΔN. Each of these recombinant proteins 
expressed in E. coli BL21 transformants with observed yields similar to that of wild-type 
EcBcsGΔN. These variant proteins were purified to apparent homogeneity using the protocol 
described previously, with no modifications (Fig. 31). Care was taken to use new 
chromatography media for the purification of each respective enzyme to prevent enzyme carry-
over and cross-contamination of assay data.   
 As expected, replacement of the catalytic nucleophile Ser278 resulted in a loss of any 
detectable activity. The observed rates of both esterase and transferase activity of the Ser278 
Ala replacement were not different from an enzyme free control (e.g. 1.96 ± 0.05 nmol min-1 
mg-1, 1.93 ± 0.13 nmol min-1 mg-1, and 1.94 ± 0.06 for the control, esterase, and transferase 
Figure 31: SDS-PAGE of purified EcBcsGΔN amino acid variants. All amino acid variants tested expressed 
and purified to near homogeneity in a fashion similar to wild-type EcBcsGΔN. Each gel shows a major 
band representing recombinant and amino-acid substituted EcBcsGΔN at 45.5 kDa. 
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activity, respectively; Fig. 32).  The next greatest observed loss of activity was measured for the 
replacement of Glu442 with Ala, also with an esterase activity indistinguishable from an enzyme-
free control (e.g. 1.96 ± 0.07 nmol min-1 mg-1; Figure 31). Only 2.3% residual transferase activity 
for the Glu442 variant could be detected in the presence of β-D-cellopentaose. 
 Similarly to Glu442, replacement of Cys243 with Ala resulted in residual specific activities 
of 4.7% (esterase) and 2.4% (transferase), consistent with the essential Zn2+-binding roles of 
these residues (Fig. 32). The His443 substitution also demonstrated reduced specific activities, 
although to a lesser degree, representing 38.5% residual esterase and 10.4% residual 
transferase activity. Furthermore, replacement of His396 with Ala produced an enzyme with a 
residual esterase activity of 16.6% and a residual transferase activity of 7.0%, consistent with 
the observation that this histidine is highly conserved and catalytically important in other pEtN 
transferases.  
Figure 32: Measured specific activities of EcBcsGΔN amino acid variants both in the absence of 
cellopentaose (esterase) and in the presence (transferase). wt = wild-type EcBcsGΔN. 
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 Replacement of Tyr277 with Phe produced an enzyme variant with greater esterase 
activity and 84% residual transferase activity compared to wild-type EcBcsGΔN (Fig. 32). This 
observation did not support our earlier conclusion that Tyr277 may function in cellulose 
accommodation in proximity to the Zn2+ ion at the active center. The thesis discussed previously 
that an equivalent tyrosine residue is not observed in available structures of other pEtN 
transferases, nor was a tyrosine residue observed to participate in contact with the lipid-
binding site in the structure of the full-length pEtN transferase EptA from Neisseria meningitidis 
(NmEptAFL; PDD ID 5FGN). Instead, the equivalent residue to Tyr277 in NmEptAFL, Ser279, appears 
to shape the lipid-binding pocket at the interface of the catalytic and membrane domains.  
Consequently, we rationalized that this disparity in our data may indicate that the role of the 
Tyr277 hydroxyl may instead be in stabilizing the local folding and interaction of the two EcBcsG 
domains, and thus, allowing for EcBcsG to sample productive conformations during the catalytic 
cycle. This hypothesis would account for the importance of Tyr277 to EcBcsG activity in vivo but 
not to EcBcsGΔN in vitro. The remainder of our variant assay data was in good agreement with 
the proposed active site, demonstrating strict dependence on the catalytic nucleophile/base 
pair Ser278/His396 and coordination of the Zn2+ ion at the active center by Cys243, Glu442 and, to a 
lesser extent, His443.  
Molecular Determinants. To assess if the loss of activity observed for substitutions of the Zn2+-
binding residues was in fact due to the loss of Zn2+ in the EcBcsGΔN active site or was due to 
structural changes in the enzyme, the metal chelating agent EDTA was supplied to EcBcsGΔN 
prior to assay. Treatment with 1 mM EDTA was observed to reduce the specific esterase activity 
of EcBcsGΔN to 10.6% of the untreated activity (Fig. 33). This significant loss of esterase activity 
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was in agreement with the large reduction in esterase activity observed for the replacement of 
Cys243, Glu442 and His443. Surprisingly, however, the loss of transferase activity observed for 
EDTA treatment was markedly less than that observed for single amino acid substitutions of the 
Zn2+-binding residues, e.g. 43% residual activity of wild-type for EDTA treated, compared to 
2.4%, 2.3% and 10.4% residual activity for replacements of Cys243, Glu442, and His443, 
respectively. This data suggests that in addition to Zn2+ binding, Cys243, Glu442 and His443 may 
also be catalytically important residues, particularly during the latter step of catalysis when 
pEtN is transferred to cellulose.  
 Subsequently, the reducing agent DTT was introduced to EcBcsGΔN to assess the 
importance of disulfide bond formation to enzymatic activity. An observed decrease in 
Figure 33: Measured specific activities of EcBcsGΔN treated with the metal chelating agent EDTA and the 
reducing agent DTT, both in the absence of cellopentaose (esterase) and in the presence (transferase). 
wt = wild-type EcBcsGΔN. 
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enzymatic activity, representing 31.9% of residual esterase activity was observed (Fig. 33). In 
contrast, the measured residual transferase activity was 72.8% of wild-type. Large reductions in 
the enzyme rate would be expected to agree with the functional complementation data, and 
result in an inadequate level of pEtN, and thus, the fragile pellicle phenotype. However, the 
limited reduction of the enzymatic rate in the presence of the reducing agent DTT is in apparent 
disagreement with the fragile pellicle phenotype of the AR3110 ΔbcsG pBcsGΔN C290A C306A, 
which displayed a pellicle phenotype not different from AR3110 ΔbcsG. This data is instead 
rationalized by the highly specific requirements of exopolysaccharide modification for biofilm 
formation. For example, the biofilm polysaccharide poly-β-(1,6)-N-acetyl-D-glucosamine, 
sometimes abbreviated PNAG, requires only partial de-acetylation by the enzyme PgaB or its 
orthologues for successful biofilm formation in various bacteria, including E. coli, S. aureus, and 
Bortadella bronchiseptica21,34,106. PNAG found in biofilms has been observed to have 
approximately 15-20% of the N-acetyl-D-glucosamine saccharide units to be deacetylated, with 
either more or less extensive deacetylation causing disruption in biofilm formation, probably 
due to the loss of a distributed cationic charge on the polymer33–35. Although a loss in EcBcsGΔN 
activity of < 30% was measured in the presence of DTT, which could be considered trivial for the 
biological function of some enzymes, the extent of pEtN modification to 50% of D-glucose 
saccharide units has been observed of pEtN cellulose biofilms isolated from E. coli or S. 
enterica32. As a result, even subtle reductions in the enzymatic rate, such as those observed 
here, could still plausibly alter the degree of pEtN substitution so that is it not matched to the 
rate of cellulose synthesis, disrupting the otherwise uniform charge and chemistry required for 
biofilm formation. 
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5.6 Evidence for the EcBcsG catalytic mechanism 
 
Identification of the covalent pEtN enzyme intermediate. A comprehensive catalytic 
mechanism for any pEtN transferase family member has yet to be experimentally elucidated72. 
Characterized enzymes belonging to the alkaline phosphatase superfamily tend to vary greatly 
in the nature and number of metal ions in the active site, based on available structures of these 
enzymes102. While the number of available structures in the pEtN transferase family remain 
limited at present, it appears that at least one catalytic zinc ion is strictly conserved and is 
indispensable for activity72,77. Several structures of MCR-1 are available, with one to four zinc 
ions observed in the active site, although Hinchcliffe et al. demonstrated that the single strictly 
conserved zinc ion is likely sufficient for at least part of the catalytic cycle72. Furthermore, pEtN 
transferases are proposed to proceed by a ping-pong bisubstrate-biproduct (bi-bi) reaction 
mechanism (Fig. 34), whereby the first step is pEtN transfer from a phospholipid to the enzyme 
catalytic nucleophile, and the second step is nucleophilic attack of the covalent pEtN 
intermediate by the acceptor substrate and turnover of the enzyme, although evidence for the 
second step and its structural feasibility remain to be seen72. The structure of EcBcsGΔN 
presented here demonstrates the presence of the single conserved catalytic zinc ion, and an 
equivalent serine in place of the family consensus catalytic threonine, satisfying all structural 
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criteria presented thus far for catalysis through the probable pEtN transferase ping pong bi-bi 
mechanism. To further investigate the hypothesis that EcBcsG proceeds through such a ping 
pong bi-bi reaction pathway, intact EcBcsGΔN was analyzed by LC- Q-TOF MS both before and 
after substrate exposure to identify the covalent enzyme intermediate, if such an intermediate 
exists (Fig. 35). The intact EcBcsGΔN mass spectra was composed of two predominant m/z 
species corresponding to molecular ions of mass 45238.57 Da and 45318.54 Da. The 45238.57 
Da species is not in agreement with the EcBcsGΔN sequence, with a theoretical molecular mass 
of 45344.98 Da. Instead, the hypothetical molecular mass of a post-translationally modified and 
mature EcBcsGΔN polypeptide, which accounts for the presence of a disulfide bond, formylation 
of the N-terminal methionine residue, and loss of the C-terminal glutamic acid residue, is in 
good agreement with the observed species, having a predicted molecular mass of 45242.84 Da. 
The second species, with a molecular mass of 45318.54 Da, corresponds to a mass shift of 
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Figure 34: Bisubstrate-biproduct reaction pathways. (A) The sequential bi-bi mechanism, in which both 
substrates bind before the release of product. (B) The ping-pong bi-bi pathway, in which the release of 
the first product and the formation of a covalent enzyme intermediate must occur before binding of the 
second substrate. 
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+79.97 Da that is indicative of protein phosphorylation (Fig. 35; panel A). The observation of a 
phosphorylated EcBcsGΔN species in solution is consistent with other pEtN transferase family 
members, for which a phosphorylated species was observed in crystallo65,72,77. However, the 
presence of a phosphorylated EcBcsGΔN, particularly with a comparatively high relative 
abundance, was surprising as phosphorylated cellooligosaccharides were never detected as 
enzymatic products by thin-layer chromatography or mass spectrometry, and suggested the 
phosphorylated species is not catalytically relevant. In addition, EcBcsGΔN was purified in the 
absence of phosphate or inorganic phosphorus, suggesting that the phosphorylation event 
Figure 35: LC- Q-ToF MS of intact EcBcsGΔN. The mass spectra of intact EcBcsGΔN (A) and of EcBcsGΔN 
following substrate exposure (B) demonstrate that BcsGΔN proceeds through a covalent pEtN-enzyme 
intermediate, and that recombinant EcBcsGΔN exists in solution as a mixed population of holo-EcBcsGΔN 
and as a phosphorylated form.  
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must have occurred in the E. coli overexpression host, and may be an artefact of cytoplasmic 
expression of the recombinant catalytic domain. 
 In an attempt to identify the site of phosphorylation, the structure of EcBcsGΔN was 
refined de novo using an unbiased calculated electron density map obtained from initial 
experimental phasing, with a spherical omit map of 10 Å centered around the catalytic zinc ion 
to remove model bias that may have been introduced during initial refinement, and before the 
detection of a phosphorylated EcBcsGΔN  polypeptide in solution state. Surprisingly, no electron 
density was calculated within 10 Å of the catalytic zinc that could be attributed to a 
phosphorylated residue. The absence of the phosphorylated EcBcsGΔN species in the structure 
presented here is reconciled by the spatial geometry of crystal packing, whereby the face of 
EcBcsGΔN presenting the active site makes crystal contacts with a molecule in a neighbouring 
asymmetric unit in both the P 212121 crystal form of EcBcsGΔN-Se and the P 21 crystal form of 
EcBcsGΔN. Thus, phosphorylation of a residue in the active site would plausibly alter the surface 
electrostatic potential of EcBcsGΔN, and may impede productive crystal packing, rationalizing 
the incorporation of only holo- EcBcsGΔN into our structural model, despite the high relative 
abundance of the phosphorylated form observed from intact protein LC- Q-TOF MS.  
 To then identify the presence of a covalent enzyme intermediate, if such a species 
exists, LC- Q-TOF mass spectra of EcBcsGΔN were collected immediately following exposure to 
the substrate analogue p-NPPE in large (300-fold) stoichiometric excess. In addition to the holo-
EcBcsGΔN (45238.57 Da) and phospho-EcBcsGΔN (45318.54 Da) species, the predominant 
molecular ion had an observed molecular mass of 45362.31 Da, a mass shift of +123.74 Da 
corresponding to the covalent addition of pEtN and representing the catalytically relevant 
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covalent enzyme intermediate (Figure 35; panel B). Moreover, the detection of the covalent 
enzyme intermediate was paralleled by a reduction in the relative intensity of the species 
corresponding to the mass of holo-EcBcsGΔN, with no apparent change in the relative 
abundance of the phosphorylated species. This observation was consistent with the hypothesis 
that the phosphorylated species may not be catalytically relevant and provides evidence that 
EcBcsGΔN proceeds through a covalent pEtN-enzyme intermediate, a requirement for the first 
step of catalysis through a ping pong bi-bi reaction mechanism.  
Determination of the EcBcsGΔN reaction order. Catalysis through a ping pong bi-bi reaction 
mechanism mandates the interaction of cosubstrates to exclusive forms of the enzyme, that is, 
the cosubstrate for the first step of the reaction mechanism, which generates the covalent 
enzyme intermediate from the free enzyme, will not subsequently interact with the covalent 
enzyme intermediate required for the second step regenerating the free enzyme, and vice 
versa107. As a consequence, the rate of formation of the covalent enzyme intermediate will still 
affect the net enzymatic rate, even when the concentration of the cosubstrate that regenerates 
the free enzyme is saturating107. Conversely, because the rate of such a mechanism depends on 
the concentration of both cosubstrates, increasing the concentration of one cosubstrate at a 
fixed concentration of the other will result in an increase in the initial rate until the 
concentration of the fixed cosubstrate becomes constraining107. These phenomena were first 
described by Cleland, often termed Cleland’s rules107. The mechanism can thus be interpreted 
from a Lineweaver-Burk reciprocal plot, where for enzymes following a ping-pong bi-bi 
mechanism, plotting the double reciprocal of initial rate against varying concentration of one 
cosubstrate at a fixed concentration of the other will result in linear relationships with unique 
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intercepts but equal slopes, demonstrating the interaction of the two cosubstrates with 
exclusive forms of the enzyme as is required for such a mechanism107. Alternately, a sequential 
bi-bi reaction pathway, in which the cosubstrates interact with the same form of the enzyme at 
some point in the catalytic cycle, would produce a double reciprocal plot of linear equations 
with equal intercepts but unique slopes107. This is observed to be true in enzymes which 
interact with both cosubstrates simultaneously, as the variation of one cosubstrate would fail 
to influence the initial rate of the enzyme when the other cosusbtrate is saturating at any non-
negligible concentration of the other107. 
 To investigate the reaction order, and thus test the hypothesis that EcBcsGΔN follows a 
ping pong bi-bi reaction pathway, the initial velocity was measured at cosubstrate 
concentrations bracketing the Km for each (0.7, 1.4, 2.1 and 2.8 mM for p-NPPE and 0.5, 1, 2 
and 2.5 mM for cellopentaose). Double reciprocal plots of initial velocity against (i) p-NPPE 
concentration at a fixed cellopentaose concentration, and (ii) cellopentaose concentration at a 
fixed p-NPPE concentration, were prepared and fit to linear models (Figure 36).  
 The resulting linear model data was analyzed with a regular one-way ANOVA, 
determining that the slopes were not significantly different from each other (i: F(3,12) = 1.275, 
p = 0.3273; ii: F(3,12) = 1.086, p = 0.3661). A Tukey’s test was conducted postanalysis for 
pairwise comparison of each slope, and none were found to be significantly different from any 
other (p > 0.3 for all cases).  A subsequent ANCOVA was performed to test the null hypothesis 
that the intercepts are equal, and the intercepts were found to be significantly different from 
each other (F(3,11) = 188.1, p < 0.0001).  
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 The observation of double reciprocal initial velocity versus cosubstrate concentration 
plots bearing parallel slopes with unique intercepts suggests that each cosubstrate used in the 
EcBcsGΔN activity assay interacts with a different form of the enzyme. Hence, according to 
Cleland’s rules, such a finding supports the hypothesis that EcBcsGΔN must proceed through a 
ping-pong bi-bi reaction mechanism. 
Identification of Ser278 as the catalytic nucleophile. A conserved catalytic threonine is 
proposed to serve the role of the catalytic nucleophile in the lipid A pEtN transferases, 
evidenced by the observation of this conserved residue as phosphothreonine in the crystal 
structures of several lipid A pEtN transferases65,72,77, and for its indispensability for catalytic 
activity in vivo72,77. However, the structure of EcBcsGΔN presented here instead possessed the 
equivalent Ser278 in place of the conserved threonine, and was never observed as 
phosphoserine in crystallo, calling into question the identity of the EcBcsGΔN catalytic 
nucleophile. To unambiguously identify the residue serving as the catalytic nucleophile, 
EcBcsGΔN was briefly exposed to the substrate analogue p-NPPE (at 15 mM) to facilitate the 
Figure 36. The reaction order of EcBcsGΔN by kinetic analysis. Lineweaver−Burk plots of initial rates of 
reaction of 50 μM EcBcsGΔN in 50 mM NaCl, 50 mM HEPES pH 7.5, using varied concentrations of p-NPPE 
(left) as the donor or cellopentaose (right) as the acceptor. Each data point represents 3 replicates. 
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formation of the covalent enzyme intermediate and was subsequently digested in sequencing-
grade trypsin. The resulting tryptic peptide library was separated and analyzed by LC- Q-TOF MS 
to identify covalently pEtN modified peptides. Approximately 91% coverage was achieved in the 
tryptic peptide library in complete agreement with the hypothetical EcBcsGΔN sequence. 
Peptides containing the predicted catalytic nucleophile Ser278 were observed, along with similar 
peptides containing a mass shift of +79.97 Da with high confidence (p < 0.0003), consistent with 
the phosphorylated EcBcsGΔN species observed in the intact EcBcsGΔN mass spectra. However, 
these peptides also contained other possible phosphorylation sites, including Ser273, Thr275, 
Ser276, and Tyr277. To then localize the site of phosphorylation, peptides identified likely to be 
phosphorylated were separated and analyzed by LC- Q-TOF MS/MS. The peptide fragment 
spectra reveal that the +79.97 Da mass shift, corresponding to phosphorylation, was localized 
to Ser278 for all phosphorylated EcBcsGΔN peptides from the trypsin digest with high confidence 
(error ≤ 0.05 Da, FDR ≤ 1%; Figure 37 & Table 6). 
 
 
Figure 37: Identification of a phosphorylated EcBcsGΔN intermediate by LC- Q-ToF MS/MS. 
Phosphorylated peptides were observed in the trypic peptide library of digested EcBcsGΔN, and 
subsequent MS/MS localized this phosphorylation to the putative catalytic nucleophile Ser278. 
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Table 6: Identification of phosphorylated peptides by LC- Q-ToF MS/MS1  
# Immonium b b-H2O b-NH3 Seq y y-H2O y-NH3 # 
1 87.06 115.05 97.04 98.02 N    15 
2 120.08 262.12 244.11 245.09 F 1521.67 1503.64 1504.65 14 
3 87.06 376.16 358.15 359.14 N 1374.59 1356.60 1357.61 13 
4 60.04 463.19 445.18 446.17 S 1260.58 1242.58 1243.54 12 
5 44.04 534.21 516.23 517.20 A 1173.53 1155.50 1156.50 11 
6 74.06 635.28 617.27 618.25 T 1102.49 1084.48 1085.47 10 
7 60.04 722.30 704.30 705.31 S 1001.49 983.45 984.42 9 
8 136.08 885.37 867.36 868.34 Y 914.40 896.40 897.39 8 
9 140.01 1052.41 1034.36 1035.35 S (+79.97) 751.35 733.34 734.32 7 
10 30.03 1109.41 1091.38 1092.39 G 584.35 566.34 567.32 6 
11 70.07 1206.45 1188.44 1189.42 P 527.32 509.32 510.30 5 
12 44.05 1277.48 1259.47 1260.46 A 430.27 412.27 413.25 4 
13 44.05 1348.52 1330.51 1331.49 A 359.24 341.23 342.21 3 
14 86.10 1461.61 1443.59 1444.58 I 288.20 270.19 271.18 2 
15 129.11    R 175.12 157.06 158.09 1 
1All b and y ions corresponding to Figure 31 are coloured in blue and red, respectively. All ions were 
detected with ≤ 0.05 Da error. 
  
  However, equivalent peptides bearing a mass shift of +123.74 Da, which would 
correspond to the covalent pEtN intermediate, were not detected. The absence of pEtN-linked 
peptides in the EcBcsGΔN tryptic peptide library was not surprising, as the covalent enzyme 
intermediate would likely be short lived and unstable in the context of active enzyme in an 
aqueous solvent, an outcome supported by the high apparent rate of esterase activity by 
EcBcsGΔN described here (8.26 μM min-1). As such, the detection of the covalent enzyme 
intermediate through tryptic digestion in solution would require the stability of the covalent 
pEtN enzyme intermediate on the order of hours, which would likely not be possible under the 
constraints of this experiment.  
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6. Summary Conclusions 
 
6.1 BcsG as a member of the phosphoethanolamine transferase family 
 
 The first objective in this thesis was a structural characterization of EcBcsG. The 
experimental approach was appropriate and successful, revealing the three-dimensional 
structure of the catalytically important C-terminal domain of EcBcsG to near-atomic resolution. 
The structural model presented in this thesis respresents a significant contribution to the field 
of microbial biofilms and the study of phosphoethanolamine transferases in several distinct 
ways. 
 First, the data presented here demonstrates that EcBcsG, and presumably, orthologous 
BcsG proteins, are both structurally and mechanistically similar to the polymyxin resistance 
factors CjEptC, NmEptA, and MCR-1. This high degree of structural similarity of EcBcsG to the 
polymyxin resistance factors is in stark contrast to its low amino acid sequence identity to these 
proteins (22.4% CjEptC, 29.4% NmEptA, 25.0% MCR-1). Additionally, EcBcsG catalyzes the 
transfer of pEtN to cellulose, while all three of the structural homologues discussed here 
catalyze the transfer of pEtN to lipid A, a vastly different substrate. However, sequence 
similarity and other in silico predictive tools estimate there are < 60 known or predicted pEtN 
transferase family members identifiable from bacterial reference genomes, as reported by 
Harper et al.63. Furthermore, phylogenetic analysis of these predicted pEtN transferases, first 
reported by Harper et al. and updated here (Figure 13), suggest the grouping of these enzymes 
into distinct subfamilies, which appear to cluster based on substrate specificity, supported by 
biochemical characterization of a limited number of the analyzed sequences available in the 
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literature. The low sequence identity of EcBcsG to all other known pEtN transferases not only 
demonstrates the limited predictive ability of sequence analysis for this family, but also 
indicates that the pEtN transferase family is likely far more expansive than predicted by Harper 
et al. Furthermore, EcBcsG does not appear to cluster with any pEtN transferase family member 
in the phylogenetic analysis, which may be indicative that EcBcsG, and related orthologues 
could represent a novel subfamily of pEtN transferases for which no other members have been 
described. 
 At present, the availability of structures of pEtN transferases is limited only to the 
polymyxin resistance factors described here. While these enzymes are functionally distinct from 
EcBcsG, it appears EcBcsG shares a highly conserved catalytic fold and mechanism, despite an 
apparent sequence dissimilarity and phylogenetic distance. Although an understanding of the 
various roles of pEtN transferases in bacteria are in their infancy, the discovery of BcsG as a 
pEtN transferase suggests that the broader pEtN transferase family may share a highly 
conserved overall fold and mechanism, despite the apparent variety of distinct reactions 
catalyzed by them. Additionally, a link between the enzymes that confer resistance to 
antimicrobial compounds and the enzymes that assemble the extracellular matrix 
demonstrates a clear and unifying emergent theme for this enzyme family, serving to enhance 
bacterial persistence and being shaped by the selective pressure of harsh, inhospitable, or 
bactericidal environments. 
 Although it was not used in the structure solution or analysis of EcBcsG discussed here, 
the structure and function of BcsG from Salmonella typhimirium (StBcsG; PDB id 5OLT) was 
published during the timeline of this thesis by Sun et al. (2018)51. The structure of EcBcsG 
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discussed here and of StBcsG, aligned using PyMOL with a r.m.s.d. of 0.531 Å across 2278 
atoms, indicating a global similarity and suggesting these enzymes are truly structural 
orthologues. Further site-directed mutagenesis studies of a limited set of residues reflected 
particular phenotypes pointing to the importance of StBcsG to the pEtN cellulose biofilm51, in 
support of the model proposed here. In conjunction, the role of the StBcsG N-terminal domain 
in assembly of the mature bacterial cellulose synthase was confirmed51, which may be further 
investigated in EcBcsG. 
6.2 BcsG is a phosphoethanolamine transferase essential for extracellular matrix 
architecture and assembly 
 
 The second objective of this thesis was a functional characterization of EcBcsG. The data 
presented here provides, for the first time, an unambiguous demonstration of the true role of 
BcsG in E. coli, both at the molecular level, and at the level of the microbial biofilm. 
Furthermore, this thesis not only presented a model for the molecular and biological roles of 
BcsG and phosphoethanolamine cellulose, but also demonstrated the molecular determinants 
for BcsG activity. 
 The discovery of phosphoethanolamine cellulose by Thongsomboon et al.32 and its 
importance in the role of infection by uropathogenic E. coli, reported by Hollenbeck et al.61 
demonstrated that the role of bcsG in microbial cellulose biosynthesis and in microbial 
pathogenesis and persistence was not trivial. This thesis demonstrates, for the first time, that 
EcBcsG-directed pEtN cellulose is required for the structural integrity of the extracellular matrix 
of E. coli. Furthermore, disruptions in the catalytic features of EcBcsG, first identified in this 
research, result in a biofilm phenotype that is indistinguishable from a chromosomal deletion of 
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bcsG.  This finding was coupled to an in vitro investigation, which demonstrated that the C-
terminal catalytic domain of EcBcsG alone, in the absence of any other Bcs complex partner, 
was sufficient to recapitulate the transfer of pEtN to various cellooligosaccharides, and that 
disruptions in the catalytic features recapitulated the lack of activity seen in vivo. 
 However, several questions about BcsG still remain. In particular, it still remains to be 
seen how the activity of BcsG is regulated to produce a polymer that is homogenously pEtN-
substituted with a precise stoichiometry of one pEtN to every-other saccharide as noted by 
Thongsomboon et al. (2018)32. Furthermore, the interaction of BcsG with other Bcs complex 
members is not well characterized, and the role of c-di-GMP and/or protein-protein 
interactions in phosphoethanolamine cellulose biosynthesis are not yet clear. The specific roles 
of bcsE and bcsF, encoded on a shared operon with bcsG, remain to be seen. Although 
identified as a novel class of c-di-GMP receptor, BcsE was not necessary for the activity of 
EcBcsGΔN in vitro. A bacterial two-hybrid study by Thongsomboon et al. showed that BcsE, BcsF 
and BcsG appear to form stable interactions in vivo, and that BcsG appears to interact with the 
BcsA/B synthase complex32. Sun et al. also demonstrated that the proper folding and 
membrane insertion of the BcsG N-terminal domain is required for proteolytic stability of 
BcsA51. However, no clear model of Bcs complex assembly is emergent from these 
observations. 
 At present, the role of c-di-GMP signalling in the control of BcsG-directed pEtN cellulose 
is unknown. Allosteric regulation of cellulose biosynthesis at the level of BcsA enzymatic activity 
is known to be dependent upon c-di-GMP binding to the PilZ domain of BcsA53, and so it is 
tempting to speculate that BcsE might serve an analogous role in the allosteric regulation of 
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BcsG activity. One other distinct mechanism of exopolysaccharide synthase complex regulation 
has been described in support of this theory108. The biosynthesis of poly-β-1,6-N-
acetylglucoasmine (PNAG), an exopolysaccharide produced by E. coli and other bacteria, is 
carried out by both PgaC and PgaD, the two inner membrane components of the PNAG 
synthesis machinery responsible for glycosyltransferase activity109. Binding of c-di-GMP to both 
PgaC and PgaD stabilizes their interaction and promotes enzyme activity resulting in PNAG 
synthesis, and proteolytic stability of PgaD in vivo is c-di-GMP dependent108.  
 Such a two-level mechanism of regulation of the pEtN cellulose synthase is certainly 
possible under the current model for its function and protein-protein interaction. Already, the 
proteolytic stability of BcsA appears to be dependent upon interaction with the BcsG N-
terminal domain51, and its activity further depends on the binding of c-di-GMP to the BcsA PilZ 
domain53. Whether the proteolytic stability or activity of BcsA and/or BcsG depends upon ligand 
binding to the BcsE GIL domain remains to be seen, although such a mechanism seems 
plausible given the apparent structural and functional homology among Gram-negative 
synthase-dependent exopolysaccharide biosynthetic machines23. 
6.3 Mechanism of action of pEtN transferases 
 The third objective of this thesis was an investigation of the catalytic mechanism of 
EcBcsG. The experimental methods and data described here were successful in demonstrating a 
limited set of the requirements for catalysis through a ping-pong bi-bi reaction mechanism. The 
results presented here support the hypothesis that pEtN transferases proceed by this 
conserved mechanism, although the molecular details of the complete catalytic cycle still have 
yet to be demonstrated. 
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 While the individual substrates for which known and predicted pEtN transferases 
catalyze transfer of pEtN vary greatly, it is generally believed that the physiological donor of 
pEtN in all cases is the membrane phospholipid phosphatidylethanolamine, enriched in the 
inner membrane of Gram-negative bacteria, and supported by experimental evidence from 
Thoingsomboon et al.32. Such a model accounts for the presence of an N-terminal 
transmembrane domain known or predicted to localize to the inner membrane for all pEtN 
transferases63. This model then supports catalysis through a ping-pong bisubstrate-biproduct 
reaction pathway, in which the catalytic domain cleaves the pEtN group with a catalytic 
nucleophile and liberating diacylglyerol as the first enzymatic product, and subsequently 
presents the pEtN to the acceptor cosubstrate, at which point it is cleaved and covalently 
bonded to the second enzymatic product72. A ping-pong mechanism of action would then 
mandate this catalytic cycle be completed in two discrete steps, where binding of the first and 
second cosubstrates occur only to the holoenzyme and the covalent enzyme intermediate, 
respectively.  However, this mechanism remains highly speculative, and the only experimental 
evidence available to support such a mechanism was reported by Hinchliffe et al.72 that density 
functional theory calculations on available structures of MCR-1 indicate that at least the first 
step of this mechanism is energetically feasible. 
 This thesis then provides, for the first time, direct and unambiguous experimental 
evidence for catalysis through a ping-pong bi-bi mechanism of action. The existence of a 
covalent pEtN-BcsG enzyme intermediate was identified and is the first enzyme in the pEtN 
transferase family known to possess such a covalent intermediate. Furthermore, Cleland’s 
rules107 were applied, and demonstrated that the apparent kinetic behaviour of BcsG support a 
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ping-pong bi-bi mechanism. Based on the existence of a covalent enzyme-intermediate, and the 
exclusion of a sequential bi-bi mechanism based on kinetic behaviour, the data presented here 
confirm that BcsG, and likely the known members of the pEtN transferase family described 
here, proceed through a ping-pong bi-bi reaction mechanism. 
 However, several mechanistic details remain to be seen, and there is limited evidence 
for the role of each essential amino acid in the catalytic cycle. For example, the results 
demonstrate that H396 and Y277 are essential for EcBcsG activity both in vivo and in vitro. 
However, the role of these amino acids cannot be inferred from the structural model of EcBcsG. 
Further efforts to experimentally resolve a BcsG-substrate complex would be required for a 
complete understanding of how these residues participate in the catalytic cycle78. Furthermore, 
the structure and in vitro activity were demonstrated using a recombinant construct of BcsG 
containing a defined truncation of the N-terminal transmembrane domain. The structure of the 
full-length NmEptA pEtN transferase, including the N-terminal transmembrane domain, was 
also reported by Anandan et al (PDB id 5FGN), and suggested how conformational change may 
influence lipid-binding, and play an important catalytic function throughout the catalytic cycle. 
Instead, our experimental approach focused on an artificial pEtN donor not linked to a lipid. 
Accordingly, the catalytic importance of a lipid-binding site in the N-terminal domain and its 
interactions with the membrane and/or other membrane proteins was not investigated. Finally, 
while the results here establish a plausible, experimentally-supported mechanism for the 
interaction of EcBcsG with the pEtN donor during the first step of the proposed catalytic cycle, 
the mechanistic basis for the binding of cellulose and subsequent transfer of pEtN during the 
second step of the catalytic cycle remain completely unknown. A complete understanding of 
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the molecular determinants of binding to both cosubstrates is required before a complete 
catalytic mechanism can be confidently proposed. 
6.4 BcsG as a therapeutic target for microbial infections  
 
 The success of this thesis in addressing all three key objectives outlined within has 
provided significant advancement of the contemporary understanding of microbial 
phosphoethanolamine cellulose biosynthesis. Beyond this, it is critically important to 
contextualize the research findings of this thesis and highlight the potential impacts and 
significance that this new knowledge will provide to collective humankind.  
 Biofilms have been estimated to be implicated in >60% of infections observed in the 
clinic3, making them an important factor in public health and infectious bacterial disease. 
Additionally, biofilm-associated genes in pathogens are considered virulence factors12, 
contributing to antimicrobial resistance. The importance of pEtN cellulose to uropathogenic E. 
coli during the course of urogenital tract infection further highlights the link between biofilm 
formation and infection20,61. Antimicrobial resistant infections are predicted to be the leading 
cause of death worldwide by 2050, surpassing annual mortality by cancer and cardiovascular 
disease79. Beyond infection, the presence of biofilms on fresh produce or other food items can 
also cause significant economic losses in addition to health concerns14. For these reasons, the 
development of new therapeutic strategies, biocontrol agents, or new clinical drugs is essential 
to combat the rising threat of recalcitrant bacterial infection and persistence.   
 The structure, activity, and mechanism of BcsG that is explored in this thesis all provide 
promising evidence that BcsG would be a suitable therapeutic target to attenuate the virulence 
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and persistence of bacteria who produce pEtN cellulose. As discussed above, the work 
presented here demonstrates that BcsG alone is essential for the architecture and assembly of 
the biofilm matrix in E. coli. Accordingly, the development of a small-molecule inhibitor, or 
other method, to abrogate BcsG activity would represent an effective strategy for the 
treatment of drug-resistant or otherwise persistent colonization by bacteria. Furthermore, the 
results in this thesis show that obstruction of pEtN cellulose is not cytotoxic to cells, and such a 
strategy to inhibit the biofilm of bacteria likely would not be met with strong selective pressure 
for resistance. This is in contrast to the emerging resistance of bacteria to conventional 
antimicrobial drugs, which has rapidly become a global threat to public health79. However, pEtN 
and phosphatidylethanolamine also contribute to eukaryotic cell membranes, and so the genes 
responsible for the biosynthesis and turnover of pEtN and pEtN-associated lipids may be 
conditionally essential to humans, making pEtN transferases a challenging molecular target. For 
example, the PHOSPHO1 gene, encoding a phosphocholine/phosphoethanolamine phosphatase 
is important for liberating inorganic phosphate in mineralizing cells110, and so disruption of the 
cellular pEtN pool may have deleterious effects on bone growth and development in humans 
and animals. Furthermore, because of the apparently conserved structure and mechanism of 
pEtN transferases explored here, such a strategy to abrogate BcsG-directed pEtN cellulose may 
also inhibit the activity of other antimicrobial drug resistance enzymes, limiting the potential for 
resistance for polymyxins - at least by the mechanisms described here. 
 The requirements for pEtN transferase activity appear to be conserved, as the results 
herein recapitulate those of Hinchcliffe et al. for MCR-172. Zinc-binding, disulfide bond 
formation, and the correct orientation and chemistry of amino acids involved in contacts with 
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either cosubstrate are indispensable for the activity of BcsG both in vivo and in vitro. This 
knowledge of the essential catalytic features of BcsG, and the resolution of its overall structure, 
represent significant advances in contemporary knowledge of bacterial cellulose biosynthesis 
and enable future efforts for structurally informed inhibitor design.  
 Although only just recently discovered in E. coli and S. enterica at the time of writing, 
pEtN cellulose represents a naturally produced, chemically modified form of cellulose which 
may prove useful as a biomaterial. The research presented in this thesis, in addition to the 
findings contributed by Hollenbeck et al.61 and Thongsomboon et al.32, demonstrate that pEtN 
cellulose has unique properties from unmodified microbial cellulose that contribute to the 
rigidity of the extracellular matrix. Although the mechanism for this apparent rigidity remains to 
be seen, Hollenbeck et al. demonstrated that pEtN cellulose appears to serve in maintaining the 
association of curli fimbriae to the bacterial cell surface61 
7. Integrative Nature of This Research 
 
 Biofilms are one of the most successful and widely distributed forms of life on Earth and 
are the predominant form of life for bacteria and archaea1,111. Biofilms are complex, self-
assembling extracellular matrices with large diversity in the biosynthesis of the materials that 
constitute them, the properties they confer to their constituents, the microorganisms that 
produce them, and the habitats they colonize. Accordingly, a complete understanding of 
biofilms requires a comprehensive model that accounts for the biological processes that govern 
them, ranging from the molecular level to the level of microbial ecology. The research 
described in this thesis concerns, primarily, the molecular mechanisms underlying the 
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biosynthesis of the exopolysaccharide from the model organism E. coli. In order to address the 
complex phenomenon of biofilms that span many levels of the hierarchy of biological science, 
the experimental approach of this thesis included a corresponding investigation of the biofilm 
at many different levels. Beginning at the level of small molecules, this research describes the 
enzymatic product of BcsG, pEtN cellulose, as well as the individual molecular determinants for 
BcsG catalysis. The thesis also addresses this phenomenon at the enzyme level, demonstrating 
the overall fold and structure of the BcsG enzyme. Furthermore, this thesis addresses the 
consequences of BcsG-mediated pEtN cellulose on the properties of the biofilm at the cellular 
and the population level using the pellicle phenotype experiment. This experimental approach 
that encompasses many levels of biology is exemplary of integrative research. 
 Beyond the study of biological processes, this thesis also describes multidisciplinary 
research spanning the disciplines of the life sciences. For example, synthetic and analytical 
chemistry were paramount to the experimental approaches used here to demonstrate the 
activity of EcBcsG in vitro. The near-atomic resolution structure of EcBcsG described here was 
accomplished by X-ray crystallography, a technique centered around modern innovations in the 
fields of physics, chemistry and mathematics. Finally, computational biology and sequence 
analysis were important experimental techniques necessary to contextualize the structure of 
EcBcsG and understand its evolutionary relationship to other known sequences and structures. 
The research described in this thesis involved many multidisciplinary approaches to answer 
important and meaningful questions about biological processes that could not be addressed 
with the conventional tools for the study of biology alone. 
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 Finally, the results presented here are the result of a largely collaborative effort, both 
within the institution and outside. The strains used in this study were the result of a 
collaboration with Thongsomboon et al., the chemical synthesis of p-NPPE was possible 
through a collaboration with Dr. Ken Maly in the Department of Chemistry & Biochemistry at 
Wilfrid Laurier University, and the mass spectrometry experiments were performed with the 
expert supervision of Dr. Armen Charchoglyan and Dr. Dyanne Brewer of the Advanced Analysis 
Facility, University of Guelph.  
 Through the study of biology at many levels, through many diverse and multidisciplinary 
techniques, and through many collaborations, the research presented here was made possible. 
For these reasons, the very nature of this thesis is Integrative Biology. 
 
8. Summary and significance 
 
     Biofilms have been estimated to be implicated in >60% of infections observed in the clinic3, 
making them an important factor in public health and infectious bacterial disease. Additionally, 
biofilm-associated genes in pathogens are considered virulence factors12, contributing to 
antimicrobial resistance. Antimicrobial resistant infections are predicted to be the leading cause 
of death worldwide by 2050, surpassing annual mortality by cancer and cardiovascular 
disease79. The presence of biofilms on fresh produce or on other foodstuff can also cause 
significant economic losses in addition to health concerns14. The structural and functional 
model of the cellulose modifying complex offers opportunities in structure-based drug 
discovery and other efforts in inhibiting microbial biofilms and limiting the resilience of biofilm-
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forming pathogens. Additionally, the new understanding of BcsG-directed 
phosphoethanolamine cellulose production provided by this thesis may enable biosynthetic 
engineering of new cellulosic materials or confer the advantages of phosphoethanolamine 
cellulose in new organisms. 
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Appendix 1 
 
Synthesis of p-nitrophenylphosphorylethanolamine. Reagents and starting materials were purchased 
from Millipore-Sigma and used as received. Anhydrous and oxygen-free solvents were dispensed from a 
custom-built solvent purification system which used purification columns packed with activated alumina 
and supported copper catalyst (Glasscontour, Irvine, CA) and maintained under argon. Melting points 
were determined on a Mel-Temp® Electrothermal melting point apparatus and are uncorrected. High 
resolution mass spectra were recorded at the Centre Régional de Spectrométrie de Masse à l’Université 
de Montréal using an Agilent LC-MSD TOF spectrometer in the ionisation mode indicated. Elemental 
analysis was conducted by Midwest Microanalysis. NMR spectra were recorded on an Agilent 
Technologies 400 MHz (1H, 13C, 19F) or 300 MHz (31P) spectrometer using deuterated solvents purchased 
from CIL Int. Chemical or Millipore-Sigma; shifts are reported (δ-scale) using the residual solvent peak as 
reference. In the case of 19F and 32P NMR no reference was used.  
 
(i) pyridin-1-ium 2-((tert-butoxycarbonyl)amino)ethyl (4-nitrophenyl) phosphate 
 
To a 100 mL 2-neck round-bottomed flask, equipped with N2 inlet and magnetic stir bar, was added p-
nitrophenyl phosphodichloridate (3.64 g, 14.2 mmol, 2 eq), dry THF (35 mL), and pyridine (2.3 mL, 28.4 
mmol, 4 eq), and the resulting clear colourless solution was cooled to 0 °C (ice-water bath). A solution of 
N-Boc-ethanolamine (1.10 mL, 7.11 mmol, 1 eq) in dry THF (20 mL) was added dropwise via syringe to 
the cold solution with formation of a white precipitate, and the mixture stirred at room temperature 
overnight. A solution of pyridine (2.3 mL, 28.4 mmol, 4 eq) in H2O (10 mL) was then added and the clear 
solution stirred 10 minutes further. The volatiles were removed via rotary evaporation yielding a yellow 
oil which was dissolved in H2O (50 mL). The aqueous layer was washed with EtOAc (3 × 50 mL), extracted 
with CH2Cl2 (3 × 50 mL), and the CH2Cl2 layer washed with H2O (1 × 25 mL), dried over Na2SO4, and 
concentrated via rotary evaporation yielding a clear oil which solidified upon standing to give a white 
solid (1.43 g, 3.24 mmol, 46%). mp (EtOAc) = 98.5−99.5 °C; 1H NMR (400 MHz, DMSO-d6) δ: 8.77 (dt, J = 
4.9, 1.6 Hz, 2H), 8.26 (tt, J = 7.8, 1.7 Hz, 1H), 8.19 (d, J = 9.2 Hz, 2H), 7.79 (dd, J = 7.8, 6.2 Hz, 2H), 7.40 (d, 
J = 9.2 Hz, 2H), 6.91 (br s, 1H), 3.85 (dt, J = 7.5, 6.0 Hz, 2H), 3.11 (q, J = 5.9 Hz, 2H), 1.33 (s, 9H); 13C NMR 
(100 MHz, DMSO-d6) δ: 158.47 (d, J = 6.1 Hz), 155.91, 145. 67, 142.97, 142.38, 126.27, 125.83, 120.78 (d, 
J = 5.4 Hz), 78.07, 65.00 (d, J = 6.3 Hz), 40.95 (d, J = 6.3 Hz), 28.57; 32P NMR (162 MHz, DMSO-d6) δ: −6.92 
(s); HRMS (ESI−): Calc. for C13H18N2O8P [M−]: 361.08063 Found: 361.08074. 
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(ii) 2-aminoethyl (4-nitrophenyl) hydrogen phosphate 
 
To a solution of N-BOC-ethanolamine pyridinium salt (850 mg, 1.92 mmol) in CH2Cl2 (10 mL) was added 
trifluoroacetic acid (0.8 mL) and allowed to stand 1.5 h. After this time the volatiles were removed via 
rotary evaporation (bath temperature ≈ 50 °C) yielding a clear, colorless oil. White crystals of the 
trifluoroacetate salt were obtained from EtOAc (7 mL) upon cooling to −15 °C overnight and collected 
via suction filtration, washing with ether (400 mg, 1.53 mmol, 79%). 1H NMR (400 MHz, D2O) δ: 8.21 (d, J  
= 8.8 Hz, 2H), 7.29 (d, J = 9.0 Hz, 2H), 4.19 (q, J = 5.7 Hz, 2H), 3.25 (t, J = 4.5 Hz, 2H); 13C NMR (100 MHz, 
D2O) δ: 157.02 (d, JC−P = 6.3 Hz), 143.56, 125.81, 120.31 (d, J = 5.0 Hz), 62.54 (d, J = 5.4 Hz), 39.79 (d, J = 
8.2 Hz); 32P NMR (121 MHz, DMSO-d6) δ: −6.71; Found: C, 36.48; H, 4.22; N, 10.56; P, 11.61. C8H11N2O6P 
requires C, 36.65; H, 4.23; N, 10.69; P, 11.81. 
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Appendix Figure A1: Annotated 1H NMR spectra for the para-nitrophenyl-N-BOC-
phosphorylethanolamine pyridinium salt synthetic intermediate. 
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Appendix Figure A2: Annotated 13C NMR spectra for the para-nitrophenyl-N-BOC-
phosphorylethanolamine pyridinium salt synthetic intermediate. 
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  Appendix Figure A3: Annotated 31P NMR spectra for the para-nitrophenyl-N-BOC-
phosphorylethanolamine pyridinium salt synthetic intermediate. 
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Appendix Figure A4: Annotated 1H NMR spectra for the para-nitrophenyl phosphorylethanolamine 
trifluoroacetate salt. Asterisks denote resident ethyl acetate sovlent detected that could not be assigned 
to the synthetic product. 
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Appendix Figure A5: Annotated 13C NMR spectra for the para-nitrophenyl phosphorylethanolamine 
trifluoroacetate salt. 
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Appendix Figure A6: Annotated 31P NMR spectra for the para-nitrophenyl phosphorylethanolamine 
trifluoroacetate salt. 
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Appendix Figure A7: Annotated 19F NMR spectra for the para-nitrophenyl phosphorylethanolamine 
trifluoroacetate salt. 
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T - - - - - I AND A Y RENNH T K K L L V L V VGE T A RA AN Y S LGGY T KND TN FY T K - KDN - - - - - - - - - - - - - - - - - - - - - -
- - - Q LDMA V VQN RP AG S L RR F V V L V VGE T T RA ANWG LNGY SRQT T P L L A A RGD E - - - - - - - - - - - - - - - - - - - - - -
T I YH A KD A VQA T K PDMRK P R L V V FV VGE T A RADH V S FNGY E RD T FPQ L A K - I DG- - - - - - - - - - - - - - - - - - - - - -
SWSD I E A AG LM SH P LWSH FD I E FKN F- - - N SA T SY SGP A A I R L L RA SCGQT SH TN L YQP ANND CY L FDN L SK LG F T
- - - - - - - - - - - - - - - - - - - V V F FDN F S SCGT A T A V S L P CM F S I SK REN Y S- - - - - - - - S SE FQEN AMD V L Y K T GVD
- - - - - - - - - - - - - - - - - - - I VN FPQV R SCGT ST AH S L P CM F ST FD RTD YD E - - - - - - I K A EHQDN L LD I VQRAGV E
- - - - - - - - - - - - - - - - - - - V TN F SN V T SCGT ST A Y SV P CM F SY LGAD E YD V - - - - - - D T A K YQEN V LD T LD R LGV S
QH LMMGHNGQ FGG F L K E V RENGGMQ SE - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - LMDQTN L P V I L LG FDG S
A VWFDNN SGGCKGV CD R L A Y KQK L S SD - - - - - - - - - - - - - - - - LD EN L L A P FK E K - LNH L SDQN I I V LH LQG SHGP
V TWL END S- GCKGV CGK V PN TD V T S LN L P - - - E Y C- - - RNGE C LDN I L L T K FD E V - LN KND KD A V L I LH T I G SHGP
I LWRDNN S- D SKGVMD K L P K AQ FAD Y K SA TNN A I CN TN P YN E CRD VGM L VG LDD FV A ANNGKDM L I M LHQMGNHGP
P V YDD T A V LN RWLD V T E KD KN SR SA T FYN T L P LHDGNH Y PGV SK T AD - - - Y K A - - - RAQK F FD E LD A F FT E L E K SG
T Y Y K RY P - - - - - - - - - - - - - - - - - SE FK K FT P T CD TN E L SK CD SE A L I N T YDN T L L Y TD Y L L SE I I K L L - K EQK - S
T Y Y E RY T - - - - - - - - - - - - - - - - - E A E RK FT P T CD TN E I N K CT RA T L VN T YDN T V L Y VDQ F I D K V I RK L - EN RD - D
A Y FK RYD - - - - - - - - - - - - - - - - - E K FA K FT P V CEGN E L A K CEHQ S L I N A YDN A L L A TDD F I AQ S I QWL - QT H SN A
RK VMV V V V P EHGGA L KGD RMQV SG L RD I P SP S I TD V P VGV K F FGMK A PHQGA P I V I EQP S S F L A I SD L V V RV LDGK
Y E S S L FY L SDHGE S LGENG I Y LHGMP Y A I A P SYQTH I P A I FWSND KN LMN L - A K E - - - - - - Y - - - - - - - - - - - KG L
L E SV VH Y V SDHGE S LGENGMY LH A A P Y A I A P SGQTH I PMVMWF SK A FRQHG- G I D - - - - - - FQC L K - - - - QK A A EN
YD V SM L Y V SDHGE S LGENGV Y LHGMPN A FA P K EQR SV P A F FWT D KQTG I T P - - - - - - - - - - - - - - - - - - - - MA T D T
I FT EDN VDWK K L T SG L PQT A P V SEN SN A V V I QYQD K P Y V R LNGGDWV P Y PQ
K L SQDN L - - - - - F ST L LGY FD V K T S- - - V - - - Y E - P E Y - D L LN P K L K AN P -
E Y SHDH Y - - - - - F ST V LG LMD I SN S- - - Q - - T Y R- K EM- D I L A A CRRP R- -
V L THD A I - - - - - T P T L L K L FD V T AD - - - K - - V KD - RT A - F I R- - - - - - - - -
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Appendix Figure A8: Complete sequence alignment of EcBcsG, CjEptC, NmEptA, and MCR-1 using ClustalOmega. 
Important active site residues are highlighted in red and alignment gaps are indicated with a hyphen.  
 
